| 2010 | ||
|
C. Loeffelholz, M. Moehlig, A. M. Arafat, F. Isken, J. Spranger, K. Mai, H. S. Randeva, A. Pfeiffer, and M. Weickert. Circulating vaspin is unrelated to insulin sensitivity in a cohort of non-diabetic humans. Eur.J Endocrinol 162 (3):507-513, 2010. |
 |
|
|
A. Henze, S. K. Frey, J. Raila, A. Scholze, J. Spranger, M. O. Weickert, M. Tepel, W. Zidek, and F. J. Schweigert. Alterations of retinol binding protein 4 species in patients with different stages of chronic kidney disease and their relation to lipid parameters. Biophys.Res.Commun. 393 (1):79-83, 2010. |
|
|
|
J. Dupuis, C. Langenberg, I. Prokopenko, R. Saxena, N. Soranzo, A. U. Jackson, E. Wheeler, N. L. Glazer, N. Bouatia-Naji, A. L. Gloyn, C. M. Lindgren, R. Magi, A. P. Morris, J. Randall, T. Johnson, P. Elliott, D. Rybin, G. Thorleifsson, V. Steinthorsdottir, P. Henneman, H. Grallert, A. Dehghan, J. J. Hottenga, C. S. Franklin, P. Navarro, K. Song, A. Goel, J. R. Perry, J. M. Egan, T. Lajunen, N. Grarup, T. Sparso, A. Doney, B. F. Voight, H. M. Stringham, M. Li, S. Kanoni, P. Shrader, C. Cavalcanti-Proenca, M. Kumari, L. Qi, N. J. Timpson, C. Gieger, C. Zabena, G. Rocheleau, E. Ingelsson, P. An, J. O'Connell, J. Luan, A. Elliott, S. A. McCarroll, F. Payne, R. M. Roccasecca, F. Pattou, P. Sethupathy, K. Ardlie, Y. Ariyurek, B. Balkau, P. Barter, J. P. Beilby, Y. Ben-Shlomo, R. Benediktsson, A. J. Bennett, S. Bergmann, M. Bochud, E. Boerwinkle, A. Bonnefond, L. L. Bonnycastle, K. Borch-Johnsen, Y. Bottcher, E. Brunner, S. J. Bumpstead, G. Charpentier, Y. D. Chen, P. Chines, R. Clarke, L. J. Coin, M. N. Cooper, M. Cornelis, G. Crawford, L. Crisponi, I. N. Day, E. J. de Geus, J. Delplanque, C. Dina, M. R. Erdos, A. C. Fedson, A. Fischer-Rosinsky, N. G. Forouhi, C. S. Fox, R. Frants, M. G. Franzosi, P. Galan, M. O. Goodarzi, J. Graessler, C. J. Groves, S. Grundy, R. Gwilliam, U. Gyllensten, S. Hadjadj, G. Hallmans, N. Hammond, X. Han, A. L. Hartikainen, N. Hassanali, C. Hayward, S. C. Heath, S. Hercberg, C. Herder, A. A. Hicks, D. R. Hillman, A. D. Hingorani, A. Hofman, J. Hui, J. Hung, B. Isomaa, P. R. Johnson, T. Jorgensen, A. Jula, M. Kaakinen, J. Kaprio, Y. A. Kesaniemi, M. Kivimaki, B. Knight, S. Koskinen, P. Kovacs, K. O. Kyvik, G. M. Lathrop, D. A. Lawlor, Bacquer O. Le, C. Lecoeur, Y. Li, V. Lyssenko, R. Mahley, M. Mangino, A. K. Manning, M. T. Martinez-Larrad, J. B. McAteer, L. J. McCulloch, R. McPherson, C. Meisinger, D. Melzer, D. Meyre, B. D. Mitchell, M. A. Morken, S. Mukherjee, S. Naitza, N. Narisu, M. J. Neville, B. A. Oostra, M. Orru, R. Pakyz, C. N. Palmer, G. Paolisso, C. Pattaro, D. Pearson, J. F. Peden, N. L. Pedersen, M. Perola, A. F. Pfeiffer, I. Pichler, O. Polasek, D. Posthuma, S. C. Potter, A. Pouta, M. A. Province, B. M. Psaty, W. Rathmann, N. W. Rayner, K. Rice, S. Ripatti, F. Rivadeneira, M. Roden, O. Rolandsson, A. Sandbaek, M. Sandhu, S. Sanna, A. A. Sayer, P. Scheet, L. J. Scott, U. Seedorf, S. J. Sharp, B. Shields, G. Sigurethsson, E. J. Sijbrands, A. Silveira, L. Simpson, A. Singleton, N. L. Smith, U. Sovio, A. Swift, H. Syddall, A. C. Syvanen, T. Tanaka, B. Thorand, J. Tichet, A. Tonjes, T. Tuomi, A. G. Uitterlinden, K. W. van Dijk, Hoek M. van, D. Varma, S. Visvikis-Siest, V. Vitart, N. Vogelzangs, G. Waeber, P. J. Wagner, A. Walley, G. B. Walters, K. L. Ward, H. Watkins, M. N. Weedon, S. H. Wild, G. Willemsen, J. C. Witteman, J. W. Yarnell, E. Zeggini, D. Zelenika, B. Zethelius, G. Zhai, J. H. Zhao, M. C. Zillikens, I. B. Borecki, R. J. Loos, P. Meneton, P. K. Magnusson, D. M. Nathan, G. H. Williams, A. T. Hattersley, K. Silander, V. Salomaa, G. D. Smith, S. R. Bornstein, P. Schwarz, J. Spranger, F. Karpe, A. R. Shuldiner, C. Cooper, G. V. Dedoussis, M. Serrano-Rios, A. D. Morris, L. Lind, L. J. Palmer, F. B. Hu, P. W. Franks, S. Ebrahim, M. Marmot, W. H. Kao, J. S. Pankow, M. J. Sampson, J. Kuusisto, M. Laakso, T. Hansen, O. Pedersen, and P. P. Pramstaller. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat.Genet. 42 (2):105-116, 2010 |
|
|
|
N. Rudovich, M. Mohlig, B. Otto, O. Pivovarova, J. Spranger, M. O. Weickert, and A. F. Pfeiffer. Effect of meglitinides on postprandial ghrelin secretion pattern in type 2 diabetes mellitus. Diabetes Technol.Ther. 12 (1):57-64, 2010. |
|
|
|
T. Bobbert, K. Mai, A. Fischer-Rosinsky, A. F. Pfeiffer, and J. Spranger. HbA1c is associated with intima media thickness in individuals with normal glucose tolerance. Diabetes Care 33 (1):203-204, 2010. |
|
|
| 2009 | ||
|
N. Rudovich, O. Pivovarova, E. Fisher, A. Fischer-Rosinsky, J. Spranger, M. Mohlig, M. B. Schulze, H. Boeing, and A. F. Pfeiffer. Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes. J Mol Med 87 (11):1145-1151, 2009 |
|
|
|
S. Liu, T. Okada, A. Assmann, J. Soto, C. W. Liew, H. Bugger, O. S. Shirihai, E. D. Abel, and R. N. Kulkarni. Insulin signaling regulates mitochondrial function in pancreatic beta-cells. PLoS.ONE. 4 (11):e7983, 2009. |
|
|
|
A. M. Arafat, M. O. Weickert, J. Frystyk, J. Spranger, C. Schofl, M. Mohlig, and A. F. Pfeiffer. The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity. J Clin Endocrinol Metab 94 (12):5093-5101, 2009. |
|
|
|
A. Tonjes, M. Koriath, D. Schleinitz, K. Dietrich, Y. Bottcher, N. W. Rayner, P. Almgren, B. Enigk, O. Richter, S. Rohm, A. Fischer-Rosinsky, A. Pfeiffer, K. Hoffmann, K. Krohn, G. Aust, J. Spranger, L. Groop, M. Bluher, P. Kovacs, and M. Stumvoll. Genetic Variation in GPR133 is Associated with Height - Genome Wide Association Study in the Self-contained Population of Sorbs. Hum.Mol Genet. 18 (23):4662-4668, 2009. |
|
|
|
P. Bobbert, A. Weithauser, J. Andres, T. Bobbert, U. Kuhl, H. P. Schultheiss, U. Rauch, and C. Skurk. Increased plasma retinol binding protein 4 levels in patients with inflammatory cardiomyopathy. Eur.J Heart Fail. 11 (12):1163-1168, 2009. |
|
|
|
A. F. Pfeiffer and S. Nitschmann. Längerfristige Effektivität unterschiedlicher Diätstrategien. Vergleich unterschiedlich hoher Fett-, Protein- bzw. Kohlenhydratanteile. Internist (Berl) 50:1290-1292, 2009. |
|
|
|
J. Spranger. Depot insulin with tumor risk. Changing now or staying cool? (interview by Sarah Pampel). MMW.Fortschr.Med 151 (30-33):22, 2009. |
|
|
|
T. Bobbert, J. Weicht, K. Mai, M. Mohlig, A. F. Pfeiffer, and J. Spranger. Acute hyperinsulinaemia and hyperlipidaemia modify circulating adiponectin and its oligomers. Clin Endocrinol (Oxf) 71 (4):507-511, 2009. |
|
|
|
S. K. Frey, J. Spranger, A. Henze, A. F. Pfeiffer, F. J. Schweigert, and J. Raila. Factors that influence retinol-binding protein 4-transthyretin interaction are not altered in overweight subjects and overweight subjects with type 2 diabetes mellitus. Metabolism 58 (10):1386-1392, 2009. |
|
|
|
F. Isken, M. O. Weickert, M. H. Tschop, R. Nogueiras, M. Mohlig, A. Abdelrahman, S. Klaus, B. Thorens, and A. F. Pfeiffer. Metabolic effects of diets differing in glycaemic index depend on age and endogenous glucose-dependent insulinotrophic polypeptide in mice. Diabetologia 52 (10):2159-2168, 2009. |
|
|
|
O. Pivovarova, O. Gogebakan, A. F. Pfeiffer, and N. Rudovich. Glucose inhibits the insulin-induced activation of the insulin-degrading enzyme in HepG2 cells. Diabetologia 52 (8):1656-1664, 2009. |
|
|
|
M. O. Weickert, B. Schofl-Siegert, A. M. Arafat, A. F. Pfeiffer, M. Mohlig, and C. Schofl. A reverse postural test as a screening tool for aldosterone-producing adenoma: a pilot study. Endocrine. 36 (1):75-82, 2009. |
|
|
|
K. Mai, J. Andres, K. Biedasek, J. Weicht, T. Bobbert, M. Sabath, S. Meinus, F. Reinecke, M. Mohlig, M. O. Weickert, M. Clemenz, A. F. Pfeiffer, U. Kintscher, S. Spuler, and J. Spranger. Free fatty acids link metabolism and regulation of the insulin-sensitizing Fibroblast Growth Factor-21. Diabetes 58 (7):1532-1538, 2009. |
|
|
|
A. Kohl, O. Gogebakan, M. Mohlig, M. Osterhoff, F. Isken, A. F. Pfeiffer, and M. O. Weickert. Increased interleukin-10 but unchanged insulin sensitivity after 4 weeks of (1, 3)(1, 6)-beta-glycan consumption in overweight humans. Nutr.Res. 29 (4):248-254, 2009. |
|
|
|
M. O. Weickert and A. F. Pfeiffer. Low-glycemic index vs high-cereal fiber diet in type 2 diabetes. JAMA 301 (15):1538-1539, 2009. |
|
|
|
F. Isken, S. Klaus, M. Osterhoff, A. F. Pfeiffer, and M. O. Weickert. Effects of long-term soluble vs. insoluble dietary fiber intake on high-fat diet-induced obesity in C57BL/6J mice. J Nutr.Biochem., 2009. |
|
|
|
O. Pivovarova, V. J. Nikiforova, A. F. Pfeiffer, and N. Rudovich. The influence of genetic variations in HHEX gene on insulin metabolism in the German MESYBEPO cohort. Diabetes Metab Res.Rev. 25 (2):156-162, 2009. |
|
|
| 2008 | ||
|
A. Fischer-Rosinsky, E. Fisher, P. Kovacs, M. Bluher, M. Möhlig, A. F. Pfeiffer, H. Boeing, and J. Spranger. Lack of Association between the Tagging SNP A+930-->G of SOCS3 and Type 2 Diabetes Mellitus: Meta-Analysis of Four Independent Study Populations. PLoS.ONE. 3 (12):e3852, 2008. |
|
|
|
C. Huth, T. Illig, C. Herder, C. Gieger, H. Grallert, C. Vollmert, W. Rathmann, Y. H. Hamid, O. Pedersen, T. Hansen, B. Thorand, C. Meisinger, A. Doring, N. Klopp, H. Gohlke, W. Lieb, C. Hengstenberg, V. Lyssenko, L. Groop, H. Ireland, J. W. Stephens, Asterholm Wernstedt, I, J. O. Jansson, H. Boeing, M. Mohlig, H. M. Stringham, M. Boehnke, J. Tuomilehto, J. M. Fernandez-Real, A. Lopez-Bermejo, L. Gallart, J. Vendrell, S. E. Humphries, F. Kronenberg, H. E. Wichmann, and I. M. Heid. Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant -174G >C with circulating glucose levels, interleukin-6 levels, and body mass index. Ann.Med:1-21, 2008. |
|
|
|
A. Henze, S. K. Frey, J. Raila, M. Tepel, A. Scholze, A. F. Pfeiffer, M. O. Weickert, J. Spranger, and F. J. Schweigert. Evidence that kidney function but not type 2 diabetes mellitus determines retinol-binding protein 4 (RBP4) serum levels. Diabetes 57 (12):3323-3326, 2008. |
|
|
|
R. Rus, C. Haag, C. Bumke-Vogt, V. Bähr, B. Mayr, M. Mohlig, E. Schulze, K. Frank-Raue, F. Raue, and C. Schofl. Novel Inactivating Mutations of the Calcium-Sensing Receptor: The Calcimimetic NPS R-568 Improves Signal Transduction of Mutant Receptors. J Clin Endocrinol Metab 93 (12):4797-4803, 2008. |
|
|
|
K. Mai, T. Bobbert, F. Reinecke, J. Andres, C. Maser-Gluth, S. A. Wudy, M. Möhlig, M. O. Weickert, M. F. Hartmann, H. M. Schulte, S. Diederich, A. F. Pfeiffer, and J. Spranger. Intravenous lipid and heparin infusion-induced elevation in free fatty acids and triglycerides modifies circulating androgen levels in women: a randomized, controlled trial. J Clin.Endocrinol Metab 93 (10):3900-3906, 2008. |
|
|
|
P. Bobbert, U. Rauch, B. Stratmann, P. Goldin-Lang, S. Antoniak, T. Bobbert, H. P. Schultheiss, and D. Tschoepe. High molecular weight adiponectin correlates positively with myeloperoxidase in patients with type 2 diabetes mellitus. Diabetes Res.Clin.Pract. 82 (2):179-184, 2008. |
|
|
|
A. Assmann, M. Möhlig, M. Osterhoff, A. F. Pfeiffer, and J. Spranger. Fatty acids differentially modify the expression of urokinase type plasminogen activator receptor in monocytes. Biochem.Biophys.Res.Commun. 376 (1):196-199, 2008. |
|
|
| D. Pomplun, S. Florian, T. Schulz, A. F. Pfeiffer, and M. Ristow. Alterations of pancreatic beta-cell mass and islet number due to Ins2-controlled expression of Cre recombinase: RIP-Cre revisited; part 2. Horm.Metab Res. 39 (5):336-340, 2007. |
|
|
| S. K. Frey, B. Nagl, A. Henze, J. Raila, B. Schlosser, T. Berg, M. Tepel, W. Zidek, M. O. Weickert, A. F. Pfeiffer, and F. J. Schweigert. Isoforms of retinol-binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver. Lipids Health Dis. 7 (1):29, 2008. |
|
|
| F. Isken, A. F. Pfeiffer, R. Nogueiras, M. A. Osterhoff, M. Ristow, B. Thorens, M. H. Tschop, and M. O. Weickert. Deficiency of Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Prevents Ovariectomy-Induced Obesity in Mice. Am J Physiol Endocrinol Metab 295:E350-E355, 2008. |
|
|
| C. Weikert, S. Westphal, K. Berger, J. Dierkes, M. Mohlig, J. Spranger, E. B. Rimm, S. N. Willich, H. Boeing, and T. Pischon. Plasma resistin levels and risk of myocardial infarction and ischemic stroke. J Clin.Endocrinol Metab 93 (7):2647-2653, 2008. |
|
|
| M. O. Weickert, M. Möhlig, J. Spranger, C. Schöfl, C. V. Loeffelholz, R. L. Riepl, B. Otto, and A. F. Pfeiffer. Effects of euglycemic hyperinsulinemia and lipid infusion on circulating cholecystokinin. J Clin.Endocrinol Metab 93 (6):2328-2333, 2008. |
|
|
| M. Möhlig, M. O. Weickert, E. Ghadamgahi, A. M. Arafat, J. Spranger, A. F. Pfeiffer, and C. Schöfl. Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome. Eur J Endocrinol 158 (4):517-523, 2008. |
|
|
| M. O. Weickert, C. V. Loeffelholz, A. M. Arafat, C. Schöfl, B. Otto, J. Spranger, M. Möhlig, and A. F. Pfeiffer. Euglycemic hyperinsulinemia differentially modulates circulating total and acylated-ghrelin in humans. J Endocrinol Invest 31 (2):119-124, 2008. |
|
|
| M. O. Weickert and A. F. Pfeiffer. Metabolic effects of dietary fiber consumption and prevention of diabetes. J Nutr. 138 (3):439-442, 2008. |
|
|
| L. Heinzerling, K. Raile, H. Rochlitz, T. Zuberbier, and M. Worm. Insulin allergy: clinical manifestations and management strategies. Allergy 63 (2):148-155, 2008. |
|
|
| T. M. Wolever, J. C. Brand-Miller, J. Abernethy, A. Astrup, F. Atkinson, M. Axelsen, I. Bjorck, F. Brighenti, R. Brown, A. Brynes, M. C. Casiraghi, M. Cazaubiel, L. Dahlqvist, E. Delport, G. S. Denyer, D. Erba, G. Frost, Y. Granfeldt, S. Hampton, V. A. Hart, K. A. Hatonen, C. J. Henry, S. Hertzler, S. Hull, J. Jerling, K. L. Johnston, H. Lightowler, N. Mann, L. Morgan, L. N. Panlasigui, C. Pelkman, T. Perry, A. F. Pfeiffer, M. Pieters, Ramdath D. Dan, R. T. Ramsingh, S. D. Robert, C. Robinson, E. Sarkkinen, F. Scazzina, D. C. Sison, B. Sloth, J. Staniforth, N. Tapola, L. M. Valsta, I. Verkooijen, M. O. Weickert, A. R. Weseler, P. Wilkie, and J. Zhang. Measuring the glycemic index of foods: interlaboratory study. Am J Clin.Nutr. 87 (1):247S-257S, 2008. |
|
|
| V. Bahr, A. F. Pfeiffer, and W. Oelkers. Is there a need for vitamin C supplementation of the normal diet? Effects of in vivo ascorbate depletion on adrenal function. Am J Clin.Nutr. 87 (1):191, 2008. |
|
|
| A. M. Arafat, M. Möhlig, M. O. Weickert, F. H. Perschel, J. Purschwitz, J. Spranger, C. J. Strasburger, C. Schöfl, and A. F. Pfeiffer. Growth Hormone Response during OGTT: The Impact of Assay Method on the Estimation of Reference Values in Patients with Acromegaly and in Healthy Controls and the Role of Gender, Age, and BMI. J Clin.Endocrinol Metab, 2008. |
|
|
| A. Fischer, E. Fisher, M. Möhlig, M. Schulze, K. Hoffmann, M. O. Weickert, R. Schueler, M. Osterhoff, A. F. Pfeiffer, H. Boeing, and J. Spranger. KCNJ11 E23K affects diabetes risk and is associated with the Disposition index: results of two independent German cohorts. Diabetes Care 31 (1):87-9, 2008 |
|
|
| M. A. Osterhoff, S. Heuer, M. Pfeiffer, J. Tasic, S. Kaiser, F. Isken, J. Spranger, M. O. Weickert, M. Mohlig, and A. F. Pfeiffer. Identification of a functional protein kinase Cbeta promoter polymorphism in humans related to insulin resistance. Mol Genet Metab 93 (2):210-5, 2007. |
|
|
| 2007 | ||
| K. Mai,J. Spranger. Body Fat Distribution and Insulin Resistance. Aktuel Ernaehr Med 32:61-64, 2007 | ||
| S. Diederich, H. M. Schulte, B. Weger, K. Mai, J. Spranger, A. F. H. Pfeiffer, and T. Bobbert. Fallbericht: Hormonelle Veränderungen durch Ausdauersport. Blickpunkt der Mann 5 (4):36-41, 2007. | ||
| A. F. Pfeiffer. Adipose tissue and diabetes therapy: do we hit the target? Horm.Metab Res. 39 (10):734-738, 2007. |
|
|
| J. Andres, K. Mai, M. Mohlig, M. O. Weickert, C. Bumke-Vogt, S. Diederich, A. F. Pfeiffer, V. Bahr, and J. Spranger. Cell-type specific regulation of the human 11beta-hydroxysteroid dehydrogenase type 1 promoter. Arch.Physiol Biochem. 113 (3):110-115, 2007. |
|
|
| T. J. Schulz, M. Glaubitz, D. Kuhlow, R. Thierbach, M. Birringer, P. Steinberg, A. F. Pfeiffer, and M. Ristow. Variable expression of cre recombinase transgenes precludes reliable prediction of tissue-specific gene disruption by tail-biopsy genotyping. PLoS.ONE. 2 (10):e1013, 2007. |
|
|
| M. Birringer, D. Kuhlow, P. T. Pfluger, N. Landes, T. J. Schulz, M. Glaubitz, S. Florian, A. Pfeiffer, M. Schuelke, R. Brigelius-Flohe, and M. Ristow. Improved glucose metabolism in mice lacking alpha-tocopherol transfer protein. Eur.J Nutr. 46 (7):397-405, 2007 |
|
|
| C. Weikert, J. Dierkes, K. Hoffmann, K. Berger, D. Drogan, K. Klipstein-Grobusch, J. Spranger, M. Möhlig, C. Luley, and H. Boeing. B Vitamin Plasma Levels and the Risk of Ischemic Stroke and Transient Ischemic Attack in a German Cohort. Stroke 38 (11):2912-8, 2007 |
|
|
| M. B. Schulze, H. U. Haring, A. F. Pfeiffer, and H. G. Joost. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes: response to schwarz et Al. Diabetes Care 30 (3):510-5, 2007. |
|
|
| M. Quinkler, J. Jussli, V. Bähr, A. F. Pfeiffer, J. Lepenies, and S. Diederich. Effect of Immunosuppressive and Other Drugs on the Cortisol-cortisone Shuttle in Human Kidney and Liver. Horm.Metab Res. 39 (8):555-559, 2007. |
|
|
| M. O. Weickert, C. V. Loeffelholz, M. Roden, V. Chandramouli, A. Brehm, P. Nowotny, M. A. Osterhoff, F. Isken, J. Spranger, B. R. Landau, A. F. Pfeiffer, and M. Möhlig. A Thr94Ala Mutation of the Human Liver Fatty Acid Binding Protein Contributes to Reduced Hepatic Glycogenolysis and Blunted Elevation of Plasma Glucose Levels in Lipid-Exposed Subjects. Am J Physiol Endocrinol Metab, ;293 (4):E1078-842007. |
|
|
| J. Dierkes, C. Weikert, K. Klipstein-Grobusch, S. Westphal, C. Luley, M. Möhlig, J. Spranger, and H. Boeing. Plasma pyridoxal-5-phosphate and future risk of myocardial infarction in the European Prospective Investigation into Cancer and Nutrition Potsdam cohort. Am J Clin.Nutr. 86 (1):214-220, 2007. |
|
|
| S. Diederich, K. Mai, V. Bähr, S. Helffrich, A. Pfeiffer, and F. H. Perschel. The Simultaneous Measurement of Plasma-Aldosterone- and -Renin-Concentration Allows Rapid Classification of all Disorders of the Renin-Aldosterone System. Exp.Clin.Endocrinol Diabetes 115 (7):433-438, 2007. |
|
|
| M. Möhlig, M. O. Weickert, E. Ghadamgadai, A. Machlitt, B. Pfuller, A. M. Arafat, A. F. Pfeiffer, and C. Schöfl. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women. Eur.J Endocrinol 157 (2):195-200, 2007. |
|
|
| S. Gruendel, A. L. Garcia, B. Otto, K. Wagner, M. Bidlingmaier, L. Burget, M. O. Weickert, G. Dongowski, M. Speth, N. Katz, and C. Koebnick. Increased acylated plasma ghrelin, but improved lipid profiles 24-h after consumption of carob pulp preparation rich in dietary fibre and polyphenols. Br.J Nutr.:98 pfeifa(6):1170-7, 2007. |
Nudeln86
|
|
| M. O. Weickert and A. F. H. Pfeiffer. Dietary fibre, glycemic index, and the prevention of Diabetes. Aktuel Ernaehr Med 32:1-6, 2007 | ||
| I. Nitz, E. Fisher, H. Grallert, Y. Li, C. Gieger, D. Rubin, H. Boeing, J. Spranger, I. Lindner, S. Schreiber, W. Rathmann, H. Gohlke, A. Doring, H. E. Wichmann, J. Schrezenmeir, F. Doring, and T. Illig. Association of Prostaglandin E Synthase 2 (PTGES2) Arg298His Polymorphism with Type 2 Diabetes in two German Study Populations. J Clin.Endocrinol Metab 92 (8):3183-8, 2007. |
|
|
| J. Raila, A. Henze, J. Spranger, M. Mohlig, A. F. Pfeiffer, and F. J. Schweigert. Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients. Kidney Int 72 (4):505-11, 2007. |
|
|
| T. Pischon, M. Mohlig, K. Hoffmann, J. Spranger, C. Weikert, S. N. Willich, A. F. Pfeiffer, and H. Boeing. Comparison of relative and attributable risk of myocardial infarction and stroke according to C-reactive protein and low-density lipoprotein cholesterol levels. Eur.J Epidemiol. 22 (7):429-38, 2007. |
|
|
| K. Mai, J. Andres, T. Bobbert, C. Maser-Gluth, M. Mohlig, V. Bahr, A. F. Pfeiffer, J. Spranger, and S. Diederich. Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue. Clin.Endocrinol (Oxf) 67 (3):419-25, 2007. |
|
|
| C. Otto, B. Otto, R. J. Frost, M. Vogeser, A. F. Pfeiffer, J. Spranger, and K. G. Parhofer. Short-term therapy with atorvastatin or fenofibrate does not affect plasma ghrelin, resistin or adiponectin levels in type 2 diabetic patients with mixed hyperlipoproteinaemia. Acta Diabetol. 44 (2):65-68, 2007. |
|
|
| J. Engl, T. Bobbert, C. Ciardi, M. Laimer, T. Tatarczyk, S. Kaser, H. Weiss, C. Molnar, H. Tilg, J. R. Patsch, J. Spranger, and C. F. Ebenbichler. Effects of pronounced weight loss on adiponectin oligomer composition and metabolic parameters. Obesity.(Silver.Spring) 15 (5):1172-1178, 2007. |
|
|
| E. Fisher, C. Weikert, M. Klapper, I. Lindner, M. Mohlig, J. Spranger, H. Boeing, J. Schrezenmeir, and F. Doring. L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women. Mol Genet Metab 91 (3):278-84, 2007 |
|
|
| J. W. Beulens, L. J. van Loon, F. J. Kok, M. Pelsers, T. Bobbert, J. Spranger, A. Helander, and H. F. Hendriks. The effect of moderate alcohol consumption on adiponectin oligomers and muscle oxidative capacity: a human intervention study. Diabetologia 50 (7):1388-92, 2007 |
|
|
| V. Bähr, W. Oelkers, A. F. Pfeiffer, and S. Diederich. Metabolism of Synthetic Steroids by the Human Placenta. Placenta 28 588-589, 2007 |
|
|
| S. Gruendel, B. Otto, A. L. Garcia, K. Wagner, C. Mueller, M. O. Weickert, W. Heldwein, and C. Koebnick. Carob pulp preparation rich in insoluble dietary fibre and polyphenols increases plasma glucose and serum insulin responses in combination with a glucose load in humans. Br.J Nutr.:98(1):101-5, 2007. |
|
|
| N. Rudovich, S. Kaiser, S. Engeli, M. Osterhoff, O. Gogebakan, M. Bluher, and A. F. Pfeiffer. GIP receptor mRNA expression in different fat tissue depots in postmenopausal non-diabetic women. Regul.Pept. 142 (3):138-45, 2007 |
|
|
| M. B. Schulze, K. Hoffmann, H. Boeing, J. Linseisen, S. Rohrmann, M. Mohlig, A. F. Pfeiffer, J. Spranger, C. Thamer, H. U. Haring, A. Fritsche, and H. G. Joost. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care 30 (3):510-515, 2007. |
|
|
| 0. E. Fisher, I. Nitz, I. Lindner, D. Rubin, H. Boeing, M. Möhlig, J. Hampe, S. Schreiber, J. Schrezenmeir, and F. Doring. Candidate gene association study of type 2 diabetes in a nested case-control study of the EPIC-Potsdam cohort - Role of fat assimilation. Mol.Nutr.Food Res. 51 (2):185-191, 2007. |
|
|
| A. F. Pfeiffer and A. Kohl. Complex dietary measures and pharmacotherapy for metabolic syndrome. Internist (Berl), 48(2):164-72, 2007. |
|
|
| S. Diederich, M. Bidlingmaier, M. Quinkler, and M. Reincke. [Diagnosis of primary hyperaldosteronism.]. Med.Klin.(Munich) 102 (1):16-21, 2007. |
|
|
| M. Steinhoff, H. Rochlitz, G. Nussbaum, J. Georgieva, and C. Zouboulis. Reduced growth of beard as the only diagnostic sign in a patient with macroprolactinoma. J Eur.Acad.Dermatol.Venereol. 21 (1):124-126, 2007. |
|
|
| S. Schnell, M. Schaefer, and C. Schofl. Free fatty acids increase cytosolic free calcium and stimulate insulin secretion from beta-cells through activation of GPR40. Mol.Cell Endocrinol 263(1-2):173-80, 2007. |
|
|
| M. O. Weickert and A. F. Pfeiffer. Reply to comment on: Weickert MO, Pfeiffer AFH (2006) Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia 49:1732-1741. Diabetologia 50 (2):495-6, 2007. |
|
|
| 0. A. L. Garcia, B. Otto, S. C. Reich, M. O. Weickert, J. Steiniger, A. Machowetz, N. N. Rudovich, M. Mohlig, N. Katz, M. Speth, F. Meuser, J. Doerfer, H. J. Zunft, A. H. Pfeiffer, and C. Koebnick. Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance. Eur.J Clin.Nutr. 61(3):334-41, 2007 |
|
|
| T. Bobbert, U. Wegewitz, L. Brechtel, M. Freudenberg, K. Mai, M. Mohlig, S. Diederich, M. Ristow, H. Rochlitz, A. F. Pfeiffer, and J. Spranger. Adiponectin Oligomers in Human Serum during Acute and Chronic Exercise: Relation to Lipid Metabolism and Insulin Sensitivity. Int.J Sports Med 28 (1):1-8, 2007. |
|
|
| Pfluger, PT, Kampe, J, Castaneda, TR, Vahl, T, D'Alessio, DA, Kruthaupt, T, Benoit, SC, Cuntz, U, Rochlitz, HJ, Möhlig, M, Pfeiffer, AFH, Koebnick, C, Weickert, MO, Otto, B, Spranger, J, and Tschöp, MH Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36 J Clin Endocrinol Metab published 92(2):583-8, 2007 |
|
|
| D. Pomplun, A. Voigt, T. J. Schulz, R. Thierbach, A. F. Pfeiffer, and M. Ristow. Reduced expression of mitochondrial frataxin in mice exacerbates diet-induced obesity. Proc.Natl.Acad.Sci.U.S.A 104 (15):6377-6381, 2007. |
|
|
| D. Pomplun, S. Florian, T. Schulz, A. F. Pfeiffer, and M. Ristow. Alterations of pancreatic beta-cell mass and islet number due to Ins2-controlled expression of Cre recombinase: RIP-Cre revisited; part 2. Horm.Metab Res. 39 (5):336-340, 2007. |
|
|
| I. Nitz, E. Fisher, C. Weikert, B. Burwinkel, Y. Li, M. Mohlig, H. Boeing, S. Schreiber, J. Schrezenmeir, and F. Doring. Association analyses of GIP and GIPR polymorphisms with traits of the metabolic syndrome. Mol Nutr.Food Res. 51 (8):1046-1052, 2007. |
|
|
| 2006 | ||
| M. Hopfner, V. Baradari, A. Huether, C. Schöfl, and H. Scherubl. The insulin-like growth factor receptor 1 is a promising target for novel treatment approaches in neuroendocrine gastrointestinal tumours. Endocr Relat Cancer 13 (1):135-149, 2006. |
|
|
| S. Gruendel, M. O. Weickert, A. L. Garcia, K. Wagner, A. F. Pfeiffer, I. Harsch, and C. Koebnick. Serum resistin increases in a postprandial state during liquid meal challenge test in healthy human subjects. J Endocrinol Invest 29 (10):RC27-RC30, 2006. |
|
|
| V. Bähr, N. Franzen, W. Oelkers, A. F. Pfeiffer, and S. Diederich. Effect of exogenous glucocorticoid on osmotically stimulated antidiuretic hormone secretion and on water reabsorption in man. Eur.J Endocrinol 155 (6):845-848, 2006. |
|
|
| 0. C. Huth, I. M. Heid, C. Vollmert, C. Gieger, H. Grallert, J. K. Wolford, B. Langer, B. Thorand, N. Klopp, Y. H. Hamid, O. Pedersen, T. Hansen, V. Lyssenko, L. Groop, C. Meisinger, A. Doring, H. Lowel, W. Lieb, C. Hengstenberg, W. Rathmann, S. Martin, J. W. Stephens, H. Ireland, H. Mather, G. J. Miller, H. M. Stringham, M. Boehnke, J. Tuomilehto, H. Boeing, M. Mohlig, J. Spranger, A. Pfeiffer, I. Wernstedt, A. Niklason, A. Lopez-Bermejo, J. M. Fernandez-Real, R. L. Hanson, L. Gallart, J. Vendrell, A. Tsiavou, E. Hatziagelaki, S. E. Humphries, H. E. Wichmann, C. Herder, and T. Illig. IL6 Gene Promoter Polymorphisms and Type 2 Diabetes: Joint Analysis of Individual Participants' Data From 21 Studies. Diabetes 55 (10):2915-2921, 2006. |
|
|
| 0. C. Otto, B. Otto, B. Goke, A. F. Pfeiffer, M. Lehrke, M. Vogeser, J. Spranger, and K. G. Parhofer. Increase in adiponectin levels during pioglitazone therapy in relation to glucose control, insulin resistance as well as ghrelin and resistin levels. J Endocrinol Invest 29 (3):231-236, 2006. |
|
|
| 0. K. Klipstein-Grobusch, M. Mohlig, J. Spranger, K. Hoffmann, F. U. Rodrigues, A. M. Sharma, S. Klaus, A. F. Pfeiffer, and H. Boeing. Interleukin-6 g.-174G>C promoter polymorphism is associated with obesity in the EPIC-Potsdam Study. Obesity.(Silver.Spring) 14 (1):14-18, 2006. |
|
|
| F. Isken, T. J. Schulz, M. Möhlig, A. F. Pfeiffer, and M. Ristow. Chemical inhibition of citrate metabolism alters glucose metabolism in mice. Horm.Metab Res. 38 (8):543-545, 2006. |
|
|
| M. O. Weickert, M. Reimann, B. Otto, W. L. Hall, K. Vafeiadou, J. Hallund, M. Ferrari, D. Talbot, F. Branca, S. Bugel, C. M. Williams, H. J. Zunft, and C. Koebnick. Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women. J Negat.Results Biomed. 5 (1):11, 2006. |
|
|
| F. Isken, T. J. Schulz, M. O. Weickert, A. F. Pfeiffer, and M. Ristow. Chemical inhibition of citrate metabolism alters body fat content in mice. Horm.Metab Res. 38 (2):134-136, 2006. |
|
|
| V. Regitz-Zagrosek, E. Lehmkuhl, and M. O. Weickert. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin.Res.Cardiol. 95 (3):136-147, 2006. |
|
|
| Möhlig, M., Flöter, A., Spranger, J., Weickert, M. O., Schill, T., Schlösser, H. W., Brabant, G., Pfeiffer, A. F., Selbig, J., Schöfl, C.: Predicting impaired glucose metabolism in women with polycystic ovary syndrome by decision tree modelling. Diabetologia.49 (11) 7572-7579, 2006 |
|
|
| García, A. L., Steiniger, J., Reich, S. C., Harsch, I., Weickert, M. O., Machowetz, A., Moehlig, M., Rudovich, N. N., Meuser, F., Doerfer, J., Katz, N., Speth, M., Zunft, H. J. F., Pfeiffer, A. F. H., Koebnick, C.: Arabinoxylan fibre improved glucose metabolism but did not affect plasma adipokines in subjects with impaired glucose tolerance. Horm. Metab. 38 (11):761-766, 2006. |
|
|
|
Weickert, M. O., Spranger, J., Holst,
J. J, Otto, B, Koebnick, C, Möhlig, M, Pfeiffer, A. F. H.:
Wheat-fibre induced changes of postprandial
peptide YY (PYY) and ghrelin responses are not associated with acute
alterations of satiety. Br. J. Nutr. 96 (5):795-798 (2006).
|
|
|
| V. Bähr, N. F. Franzen, A. F. Pfeiffer, S. Diederich, and W. Oelkers. Vasopressin excess and hyponatremia: hydrocortisone treatment should be considered. Am.J Kidney Dis. 48 (2):339-340, 2006. |
|
|
| K. Mai, T. Bobbert, V. Kullmann, J. Andres, V. Bahr, C. Maser-Gluth, H. Rochlitz, J. Spranger, S. Diederich, and A. F. Pfeiffer. No effect of free fatty acids on adrenocorticotropin and cortisol secretion in healthy young men. Metabolism 55 (8):1022-1028, 2006. |
|
|
| A. M. Arafat, F. H. Perschel, B. Otto, M. O. Weickert, H. Rochlitz, C. Schöfl, J. Spranger, M. Möhlig, and A. F. Pfeiffer. Glucagon Suppression of Ghrelin Secretion is exerted at Hypothalamus-Pituitary Level. J Clin.Endocrinol Metab 91 (9) 3528-3533, 2006. |
|
|
| M. Möhlig, A. Jurgens, J. Spranger, K. Hoffmann, M. O. Weickert, H. W. Schlosser, T. Schill, G. Brabant, A. Schuring, A. F. Pfeiffer, J. Gromoll, and C. Schöfl. The androgen receptor CAG repeat modifies the impact of testosterone on insulin resistance in women with polycystic ovary syndrome. Eur.J Endocrinol 155 (1):127-130, 2006. |
|
|
| E. Fisher, Y. Li, B. Burwinkel, V. Kuhr, K. Hoffmann, M. Mohlig, J. Spranger, A. Pfeiffer, H. Boeing, J. Schrezenmeir, and F. Doring. Preliminary Evidence of FABP2 A54T Polymorphism Associated with Reduced Risk of Type 2 Diabetes and Obesity in Women from a German Cohort. Horm.Metab Res. 38 (5):341-345, 2006. |
|
|
| Y. Li, E. Fisher, M. Klapper, H. Boeing, A. Pfeiffer, J. Hampe, S. Schreiber, B. Burwinkel, J. Schrezenmeir, and F. Doring. Association Between Functional FABP2 Promoter Haplotype and Type 2 Diabetes. Horm.Metab Res. 38 (5):300-307, 2006. |
|
|
| M. O. Weickert and A. F. Pfeiffer. Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia, 49:1732-1741, 2006 |
|
|
| D. Rubin, U. Helwig, M. Pfeuffer, S. Schreiber, H. Boeing, E. Fisher, A. Pfeiffer, S. Freitag-Wolf, U. R. Foelsch, F. Doering, and J. Schrezenmeir. A common functional exon polymorphism in the microsomal triglyceride transfer protein gene is associated with type 2 diabetes, impaired glucose metabolism and insulin levels. J.Hum.Genet., 2006. |
|
|
| S. Gruendel, A. L. Garcia, B. Otto, C. Mueller, J. Steiniger, M. O. Weickert, M. Speth, N. Katz, and C. Koebnick. Carob pulp preparation rich in insoluble dietary fiber and polyphenols enhances lipid oxidation and lowers postprandial acylated ghrelin in humans. J.Nutr. 136 (6):1533-1538, 2006. |
|
|
| R. Mohan, P. Namsolleck, P. A. Lawson, M. Osterhoff, M. D. Collins, C. A. Alpert, and M. Blaut. Clostridium asparagiforme sp. nov., isolated from a human faecal sample. Syst.Appl.Microbiol. 29 (4):292-299, 2006. |
|
|
| C. Koebnick, K. Wagner, A. L. Garcia, S. Gruendel, P. H. Lahmann, M. O. Weickert, M. Mohlig, I. A. Harsch, C. Einig, M. Speth, N. Katz, U. Trippo, and H. J. Zunft. Increase in serum resistin during weight loss in overweight subjects is related to lipid metabolism. Int.J.Obes.(Lond) 30:1097-1103, 2006. |
|
|
| M. Möhlig, J. Spranger, M. Ristow, A. F. Pfeiffer, T. Schill, H. W. Schlosser, L. Moltz, G. Brabant, and C. Schöfl. Predictors of abnormal glucose metabolism in women with polycystic ovary syndrome. Eur.J.Endocrinol. 154 (2):295-301, 2006. |
|
|
| K. Mai, T. Bobbert, V. Kullmann, J. Andres, H. Rochlitz, M. Osterhoff, M. O. Weickert, V. Bähr, M. Mohlig, A. F. Pfeiffer, S. Diederich, and J. Spranger. Free fatty acids increase androgen precursors in vivo. J.Clin.Endocrinol.Metab. 91(4):1501-1507, 2006. |
|
|
| T. J. Schulz, R. Thierbach, A. Voigt, G. Drewes, B. H. Mietzner, P. Steinberg, A. F. Pfeiffer, and M. Ristow. Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth: Otto Warburg revisited. J Biol.Chem. 281:977-981, 2006 |
|
|
| Weickert, M. O., Möhlig, M., Schöfl, C. Arafat, A. M., Otto, B., Viehoff, H., Koebnick, C., Kohl, A., Spranger, J., Pfeiffer, A. F. H.: Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care. 29 (4):775-780, (2006). |
|
|
|
Möhlig, M., Freudenberg, M., Bobbert, T.,
Ristow, M., Rochlitz, H., Weickert, M. O., Pfeiffer, A. F. H., Spranger,
J: Acetylsalicylic acid improves lipid-induced
insulin resistance in healthy men. J. Clin. Endocrinol. Metab.
91(3):964-7, (2006).
|
|
|
| J. Spranger, S. Verma, I. Gohring, T. Bobbert, J. Seifert, A. L. Sindler, A. Pfeiffer, S. M. Hileman, M. Tschop, and W. A. Banks. Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 55 (1):141-147, 2006. |
|
|
| 2005 | ||
| K. Prank, M. Waring, U. Ahlvers, A. Bader, E. Penner, M. Moller, G. Brabant, and C. Schöfl. Precision of intracellular calcium spike timing in primary rat hepatocytes. Syst.Biol.(Stevenage.) 2 (1):31-34, 2005. |
|
|
|
Weickert, M. O., Pfeiffer, A. F. H.:
Dietary fibre and the prevention of type 2
diabetes mellitus. Ernährung & Medizin 20, 185-189 (2005).
|
||
| M. Möhlig, C. Koebnick, M. O. Weickert, W. Lueder, B. Otto, J. Steiniger, M. Twilfert, F. Meuser, A. F. Pfeiffer, and H. J. Zunft. Arabinoxylan-enriched meal increases serum ghrelin levels in healthy humans. Horm.Metab Res. 37 (5):303-308, 2005. |
|
|
| R. Thierbach, T. J. Schulz, F. Isken, A. Voigt, B. Mietzner, G. Drewes, J. C. von Kleist-Retzow, R. J. Wiesner, M. A. Magnuson, H. Puccio, A. F. Pfeiffer, P. Steinberg, and M. Ristow. Targeted Disruption of Hepatic Frataxin Expression Causes Impaired Mitochondrial Function, Decreased Life Span, and Tumor Growth in Mice. Hum.Mol.Genet. 14:3857-3864, 2005. |
|
|
| M. O. Weickert, M. Möhlig, C. Koebnick, J. J. Holst, P. Namsolleck, M. Ristow, M. Osterhoff, H. Rochlitz, N. Rudovich, J. Spranger, and A. F. Pfeiffer. Impact of cereal fibre on glucose-regulating factors. Diabetologia 48 (11):2343-2353, 2005. |
|
|
| Bobbert, T., Brechtel, L., Mai, K., Otto, B., Maser-Gluth, C., Pfeiffer, A. F., Spranger, J., and Diederich, S. Adaptation of the hypothalamic-pituitary hormones during intensive endurance training. Clin Endocrinol (Oxf) 63(5):530-536 (2005) |
|
|
| Mai, K., Kullmann, V., Bobbert, T., Maser-Gluth, C., Möhlig, M., Bähr, V., Pfeiffer, A. F., Spranger, J., and Diederich, S. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance. Clin Endocrinol (Oxf). 63:442-449 (2005) |
|
|
| Lindner, I., Helwig, U., Rubin, D., Li, Y., Fisher, E., Boeing, H., Möhlig, M., Spranger, J., Pfeiffer, A., Hampe, J., Schreiber, S., Döring, F., and Schrezenmeir, J. Putative association between a new polymorphism in exon 3 (Arg109Cys) of the pancreatic colipase gene and type 2 diabetes mellitus in two independent Caucasian study populations. Mol.Nutr.Food Res. 49:972-976 (2005) |
|
|
| T. Bobbert, H. Rochlitz, U. Wegewitz, S. Akpulat, K. Mai, M. O. Weickert, M. Mohlig, A. F. Pfeiffer, and J. Spranger. Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes 54 (9):2712-2719, 2005. |
|
|
| Arafat, M. A., Otto, B., Rochlitz, H., Tschop, M., Bähr, V., Mohlig, M., Diederich, S., Spranger, J., and Pfeiffer, A. F. H. Glucagon inhibits ghrelin secretion in humans. Europ.J.Endocrin. 153(3):397-402 (2005) |
|
|
| Bähr, V. Does Estradiol induced inhibition of 11beta-hydroxysteroid dehydrogenase 1 explain effects of the postmenopausal hormone replacement therapy? Med.Hypotheses (2005) |
|
|
|
Jurgens, H., Haass, W., Castaneda, T. R., Schurmann, A., Koebnick, C., Dombrowski, F., Otto, B., Nawrocki, A. R., Scherer, P. E., Spranger, J., Ristow, M., Joost, H. G., Havel, P. J., and Tschop, M. H. Consuming Fructose-sweetened Beverages Increases Body Adiposity in Mice. Obes.Res 13(7):1146-1156 (2005) |
|
|
| Wegewitz, U., Gohring, I., and Spranger, J. Novel approaches in the treatment of angiogenic eye disease. Curr.Pharm.Des 11(18):2311-2330 (2005) |
|
|
| Otto, B., Spranger, J., Benoit, S. C., Clegg, D. J., and Tschop, M. H. The many faces of ghrelin: new perspectives for nutrition research? Br.J Nutr. 93(6):765-771 (2005) |
|
|
| Schöfl,C., Luebben,G. Pioglitazone Improves Diabetic Dyslipidaemia in Patients with Type 2 Diabetes Mellitus with or without Lipid-Lowering Therapy. Clin.DrugInvest. 25(5):341-345 (2005) | ||
| Kopp, H. P., Krzyzanowska, K., Mohlig, M., Spranger, J., Pfeiffer, A. F., and Schernthaner, G. Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int.J Obes.Relat Metab Disord. 29(7):766-71 (2005) |
|
|
| Weickert, M. O. and Pfeiffer, A. F. [Preventing type 2 diabetes: what does dietary fiber achieve?]. MMW.Fortschr.Med. 147(17):28-30 (2005) |
|
|
| Pfeiffer, A. F. [Treat insulin resistance and look out for mental stress. New strategies in the prevention of type 2 diabetes]. MMW.Fortschr.Med. 147(17):27(2005) |
|
|
| Heidemann, C., Hoffmann, K., Spranger, J., Klipstein-Grobusch, K., Möhlig, M., Pfeiffer, A. F., and Boeing, H. A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study cohort. Diabetologia (2005) |
|
|
| Prank,K., Waring,M., Ahlvers,U., Bader,A., Penner,E., Moller,M., Brabant,G., Schöfl,C. Precision of intracellular calcium spike timing in primary rat hepatocytes.Systems biology 2(1):31-34 (2005) | ||
| Jacobs, B., Muller, M. K., and Pfeiffer, A. F. [Diabetes mellitus with massive leg edema without heart failure.]. Dtsch.Med.Wochenschr. 130(17):1074-1077 (2005) |
|
|
| Rochlitz, H., Akpulat, S., Bobbert, T., Mai, K., Mohlig, M., Osterhoff, M., Weickert, M. O., Pfeiffer, A. F., and Spranger, J. [Changes of biomarkers during weight reduction in metabolic syndrome.]. Dtsch.Med.Wochenschr. 130(17):1061-1066 (2005) |
|
|
| Pfeiffer, A. F. [Strategies for prevention of prediabetes.]. Dtsch.Med.Wochenschr. 130(17):1059-1060 (2005) |
|
|
| Hauner, H., Landgraf, R., Schulze, J., Spranger, J., and Standl, E. [Prevention of type 2 diabetes mellitus.]. Dtsch.Med.Wochenschr. 130(17):1053-1054 (2005) |
|
|
| Kremenevskaja, N., von, Wasielewski R., Rao, A. S., Schöfl, C., Andersson, T., and Brabant, G. Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene (2005) |
|
|
| Andres, J. In-vitro-Mutagenese der humanen 11β-Hydroxysteroid Dehydrogenase und deren funktionelle Charakterisierung in E.coli Diplomarbeit im Fachbereich Biochemie an der Universität Potsdam 2004 |
 |
|
| Eigendorff, E. Metabolism of synthetic steroids by 11ß-hydroxysteroid dehydrogenases - in vivo and in vitro studies. Dissertation Charité 2005 |
|
|
| Kluth, D., Landes, N., Pfluger, P., Muller-Schmehl, K., Weiss, K., Bumke-Vogt, C., Ristow, M., and Brigelius-Flohe, R. Modulation of Cyp3a11 mRNA expression by alpha-tocopherol but not gamma-tocotrienol in mice. Free Radic.Biol.Med. 38(4):507-514 (2005) |
|
|
| Rudovich, N. N., Dick, D., Moehlig, M., Otto, B., Spranger, J., Rochlitz, H. J., Ristow, M., Tschoep, M., and Pfeiffer, A. F. Ghrelin is not suppressed in hyperglycemic clamps by gastric inhibitory polypeptide and arginine. Regul.Pept. 127(1-3):95-99 (2005) |
|
|
| 0. R. A. Shellie, W. Welthagen, J. Zrostlikova, J. Spranger, M. Ristow, O. Fiehn, and R. Zimmermann. Statistical methods for comparing comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry results: metabolomic analysis of mouse tissue extracts. J Chromatogr.A 1086 (1-2):83-90, 2005. |
|
|
| 2004 | ||
| Rudovich, N. N., Leyck Dieken, M. G., Rochlitz, H., and Pfeiffer, A. F. Enhancement of early- and late-phase insulin secretion and insulin sensitivity by the combination of repaglinide and metformin in type 2 diabetes mellitus. Exp.Clin Endocrinol Diabetes 112(7):395-400 (2004) |
|
|
| Rudovich, N. N., Rochlitz, H. J., and Pfeiffer, A. F. Reduced hepatic insulin extraction in response to gastric inhibitory polypeptide compensates for reduced insulin secretion in normal-weight and normal glucose tolerant first-degree relatives of type 2 diabetic patients. Diabetes 53(9):2359-2365 (2004) |
|
|
| Altmeyer, M. 141 patients with incidentally found adrenal tumour: development of a rational diagnostic and therapeutic algorithm. Dissertation Charité 2004 |
|
|
| Bähr, V., Bumke-Vogt, C., Götze, J., Pfeiffer, A. F., and Diederich, S. Function of human mineralocorticoid receptor splice variant. Eur.J.Endocrinol. 151(2):295(2004) |
|
|
| Bornstein, S. R. and Oelkers, W. Adrenal function and metabolism. Horm.Metab Res. 36(6):341-345 (2004) | ||
| de Bruin, R. A., Bouhuizen, A., Diederich, S., Perschel, F. H., Boomsma, F., and Deinum, J. Validation of a new automated Renin assay. Clin.Chem. 50(11):2111-2116 (2004) |
|
|
| Diederich, S., Scholz, T., Eigendorff, E., Bumke-Vogt, Ch, Quinkler, M., Exner, P., Pfeiffer, A. F., Oelkers, W., and Bähr, V. Pharmacodynamics and Pharmacokinetics of Synthetic Mineralocorticoids and Glucocorticoids: Receptor Transactivation and Prereceptor Metabolism by 11beta-hydroxysteroid-dehydrogenases. Horm.Metab Res. 36(6):423-429 (2004) |
|
|
| Franzen, N.-F. Influence of glucocorticoids on Vasopressin-secretion in man. Dissertation Charité 2004 |
|
|
| Grossmann, C., Scholz, T., Rochel, M., Bumke-Vogt, C., Oelkers, W., Pfeiffer, A. F., Diederich, S., and Bähr, V. Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties. Eur.J.Endocrinol. 151(3):397-406 (2004) |
|
|
| Möhlig, M., Isken, F., and Ristow, M. Impaired mitochondrial activity and insulin-resistant offspring of patients with type 2 diabetes. N.Engl.J.Med. 350(23):2419-2421 (2004) |
|
|
| Möhlig, M., Boeing, H., Spranger, J., Osterhoff, M., Kroke, A., Fisher, E., Bergmann, M. M., Ristow, M., Hoffmann, K., and Pfeiffer, A. F. Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes. J.Clin.Endocrinol.Metab 89(4):1885-1890 (2004) |
|
|
| Möhlig, M., Spranger, J., Osterhoff, M., Ristow, M., Pfeiffer, A. F., Schill, T., Schlosser, H. W., Brabant, G., and Schofl, C. The polycystic ovary syndrome per se is not associated with increased chronic inflammation. Eur.J.Endocrinol. 150(4):525-532 (2004) |
|
|
| Oelkers, W. Mineralocorticoid substitution in pregnant Addisonian women. J.Endocrinol.Invest 27(4):406(2004) |
|
|
| Oelkers, W. Drospirenone, a progestogen with antimineralocorticoid properties: a short review. Mol.Cell Endocrinol. 217(1-2):255-261 (2004) |
|
|
| Otto, B., Tschop, M., Heldwein, W., Pfeiffer, A. F., and Diederich, S. Endogenous and exogenous glucocorticoids decrease plasma ghrelin in humans. Eur.J.Endocrinol. 151(1):113-117 (2004) |
|
|
| Perschel, F. H., Schemer, R., Seiler, L., Reincke, M., Deinum, J., Maser-Gluth, C., Mechelhoff, D., Tauber, R., and Diederich, S. Rapid Screening Test for Primary Hyperaldosteronism: Ratio of Plasma Aldosterone to Renin Concentration Determined by Fully Automated Chemiluminescence Immunoassays. Clin.Chem. 50(9):1650-1655 (2004) |
|
|
| Pomplun, D., Mohlig, M., Spranger, J., Pfeiffer, A. F., and Ristow, M. Elevation of blood glucose following anaesthetic treatment in C57BL/6 mice. Horm.Metab Res. 36(1):67-69 (2004) |
|
|
| Quinkler, M., Diederich, S., Bähr, V., and Oelkers, W. The role of progesterone metabolism and androgen synthesis in renal blood pressure regulation. Horm.Metab Res. 36(6):381-386 (2004) |
|
|
| Quinkler, M., Bappal, B., Draper, N., Atterbury, A. J., Lavery, G. G., Walker, E. A., DeSilva, V., Taylor, N. F., Hala, S., Rajendra, N., and Stewart, P. M. Molecular basis for the Apparent Mineralocorticoid Excess Syndrome in the Oman population. Mol.Cell Endocrinol. 217(1-2):143-149 (2004) |
|
|
| Quinkler, M., Sinha, B., Tomlinson, J. W., Bujalska, I. J., Stewart, P. M., and Arlt, W. Androgen generation in adipose tissue in women with simple obesity - a site-specific role for 17beta-hydroxysteroid dehydrogenase type 5. J.Endocrinol. 183(2):331-342 (2004) |
|
|
| Schöfl,C., Schill,T., Geishövel,F., Brabant,G. Polyzystisches Ovarialsyndrom. Deutsches Ärzteblatt 101:A346-A351, 2004. | ||
| Ristow, M. Neurodegenerative disorders associated with diabetes mellitus. J.Mol.Med. 82:510-529 (2004) |
|
|
| Schumm-Draeger, P. M., Diederich, S., Doren, M., Fassbender, W. J., Mann, B., Raue, F., Schilling, T., Weber, M. M., and Pfeiffer, A. F. Endokrinologie - Teil 2. Med.Klin.(Munich) 99(7):372-382 (2004) |
|
|
| Scholz,T. Agonism of synthetic glucocorticoids via the gluco- and the mineralocorticoid receptor of man in a CV-1 cell system. Dissertation Charité 2004 |
|
|
| Spranger, J., Mohlig, M., Wegewitz, U., Ristow, M., Pfeiffer, A. F., Schill, T., Schlosser, H. W., Brabant, G., and Schofl, C. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 61(6):738-746 (2004) |
|
|
|
|
|
| 2003 | ||
| Bähr, V., Oelkers, W., and Diederich, S. Monogenetische Hypertonien. Med.Klin. 98(4):208-217 (2003) |
|
|
| Bähr, V., Bumke-Vogt, C., Götze, J., Diederich, S., and Pfeiffer, A. F. H. Transactivation by an important human mineralocorticoid receptor splice variant with four additional amino acids in the DNA binding domain. Aldosteron International Symposium, London 2003 (2003) | ||
| Diederich, S., Eigendorff, E., Schöneshöfer, M., Quinkler, M., Oelkers, W., and Bähr, V. In vivo evaluation of 11ß-hydroxysteroid-dehydrogenases in man. Exp Clin Endocrinol Diabetes 111(Suppl.1):S18-S19 (2003) | ||
| Diederich, S. Endokriner und parakriner Metabolismus von endogenen und synthetischen Steroidhormonen. Habilitationsschrift zur Erlangung der venia legendi für das Fach Innere Medizin. Aus der Medizinischen Klinik IV, Endokrinologie, Diabetologie und Ernährungsmedizin, Universitätsklinikum Benjamin Franklin, Freie Univerität Berlin :Seiten 17-18, 41(2003) | ||
| Engeli, S., Feldpausch, M., Gorzelniak, K., Hartwig, F., Heintze, U., Janke, J., Mohlig, M., Pfeiffer, A. F., Luft, F. C., and Sharma, A. M. Association Between Adiponectin and Mediators of Inflammation in Obese Women. Diabetes 52(4):942-947 (2003) |
|
|
| Jusli, J., Diederich, S., Bähr, V., Pfeiffer, A., and Quinkler, M. Influence of immunosuppressive drugs and other compounds on human renal 11ß-hydroxsteroid dehydrogenase (11ß-HSD) type 2 in vitro. Exp Clin Endocrinol Diabetes 111(Suppl.1):S31-S31 (2003) | ||
| Kopp, R., Rothbauer, E., Mueller, E., Schildberg, F. W., Jauch, K. W., and Pfeiffer, A. Reduced survival of rectal cancer patients with increased tumor epidermal growth factor receptor levels. Dis.Colon Rectum 46(10):1391-1399 (2003) |
|
|
| Kopp, R., Rothbauer, E., Ruge, M., Arnholdt, H., Spranger, J., Muders, M., Pfeiffer, D. G., Schildberg, F. W., and Pfeiffer, A. Clinical implications of the EGF receptor/ligand system for tumor progression and survival in gastrointestinal carcinomas: evidence for new therapeutic options. Recent Results Cancer Res 162:115-32.:115-132 (2003) |
|
|
| Oelkers, W. Introduction. Hormone replacement therapy and the cardiovascular system: targeting the RAAS. Climacteric. 6 Suppl 3:11-2.:11-12 (2003) |
|
|
| Meyer, M.C. Determination of the agonistic and antagonistic potency of progesterone metabolites at the human mineralocorticoid receptor in vitro and the antimineralocorticoid potency of progesterone and the human metabolism of progesterone in vivo. Dissertation Charité 2003 |
|
|
| Osterhoff, M., Mohlig, M., Schwanstecher, M., Seufert, J., Ortmann, J., Schatz, H., and Pfeiffer, A. F. Ca(2+)/calmodulin-dependent protein kinase II delta(2) regulates gene expression of insulin in INS-1 rat insulinoma cells. Cell Calcium 33(3):175-184 (2003) |
|
|
| Perschel, F. H., Schermer, R., and Diederich, S. Plasma-aldosterone plasma-renin concentration ratio in healthy volunteers. Exp Clin Endocrinol Diabetes 111(S1):S49-S49 (2003) | ||
| Quinkler, M., Bumke-Vogt, C., Meyer, B., Bähr, V., Oelkers, W., and Diederich, S. The human kidney is a progesterone-metabolizing and androgen-producing organ. J.Clin.Endocrinol.Metab 88(6):2803-2809 (2003) |
|
|
| Quinkler, M., Troeger, H., Eigendorff, E., Maser-Gluth, C., Stiglic, A., Oelkers, W., Bähr, V., and Diederich, S. Enhanced 11beta-hydroxysteroid dehydrogenase type 1 activity in stress adaptation in the guinea pig. J Endocrinol. 176(2):185-192 (2003) |
|
|
| Quinkler, M., Lepenies, J., and Diederich, S. [Diagnosis of adrenal insufficiency]. Dtsch.Med.Wochenschr. 128(11):556-561 (2003)12626438 |
|
|
| Quinkler, M. and Stewart, P. M. Hypertension and the cortisol-cortisone shuttle. J.Clin.Endocrinol.Metab 88(6):2384-2392 (2003) |
|
|
| Quinkler, M., Meyer, B., Oelkers, W., and Diederich, S. Renal inactivation, mineralocorticoid generation, and 11beta-hydroxysteroid dehydrogenase inhibition ameliorate the antimineralocorticoid effect of progesterone in vivo. J.Clin.Endocrinol.Metab 88(8):3767-3772 (2003) |
|
|
| Quinkler, M., Lepenies, J., and Diederich, S. [Therapy of adrenal cortex insufficiency]. Dtsch.Med.Wochenschr. 128(12):617-618 (2003) |
|
|
| Remizov, O., Jakubov, R., Dufer, M., Krippeit, Drews P., Drews, G., Waring, M., Brabant, G., Wienbergen, A., Rustenbeck, I., and Schofl, C. Palmitate-induced Ca2+-signaling in pancreatic beta-cells. Mol.Cell Endocrinol 212(1-2):1-9 (2003) |
|
|
| Ristow, M., Mulder, H., Pomplun, D., Schulz, T. J., Muller-Schmehl, K., Krause, A., Fex, M., Puccio, H., Muller, J., Isken, F., Spranger, J., Muller-Wieland, D., Magnuson, M. A., Mohlig, M., Koenig, M., and Pfeiffer, A. F. Frataxin deficiency in pancreatic islets causes diabetes due to loss of {beta} cell mass. J.Clin.Invest. 112(4):527-534 (2003) |
|
|
| Schöfl, C., Lübben,G. Postmarketing surveillance study of the efficacy and tolerability of pioglitazone in insulin-resistant patients with type 2 diabetes mellitus in general practice. Clin Drug Invest 23:725-734, 2003. | ||
| Spranger, J., Kroke, A., Mohlig, M., Bergmann, M. M., Ristow, M., Boeing, H., and Pfeiffer, A. F. Adiponectin and protection against type 2 diabetes mellitus. Lancet 361(9353):226-228 (2003) |
|
|
| Spranger, J., Kroke, A., Mohlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., Boeing, H., and Pfeiffer, A. F. Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes: Results of the Prospective Population-Based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52(3):812-817 (2003) |
|
|
| Spranger, J., Ristow, M., Otto, B., Heldwein, W., Tschop, M., Pfeiffer, A. F., and Mohlig, M. Post-prandial decrease of human plasma ghrelin in the absence of insulin. J.Endocrinol.Invest 26(8):RC19-RC22 (2003) |
|
|
| Tschop, M., Arlt, W., Anker, S., and Ristow, M. Perspektiven des medizinischakademischen Nachwuchses in Deutschland. Urologe A 42(9):1290-1293 (2003) |
|
|
| Diederich, S., Franzen, N. F., Bähr, V., and Oelkers, W. Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases. Eur.J.Endocrinol. 148(6):609-617 (2003) |
|
|
| 2002 | ||
| Bähr, V., Pfeiffer, A. F., and Diederich, S. The metabolic syndrome x and peripheral cortisol synthesis. Exp Clin Endocrinol Diabetes 110(7):313-318 (2002) |
|
|
| Bumke-Vogt, C., Bähr, V., Diederich, S., Herrmann, S. M., Anagnostopoulos, I., Oelkers, W., and Quinkler, M. Expression of the progesterone receptor and progesterone- metabolising enzymes in the female and male human kidney. J Endocrinol. 175(2):349-364 (2002) |
|
|
| Diederich, S., Eigendorff, E., Burkhardt, P., Quinkler, M., Bumke-Vogt, C., Rochel, M., Seidelmann, D., Esperling, P., Oelkers, W., and Bähr, V. 11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids. J.Clin.Endocrinol.Metab 87(12):5695-5701 (2002) |
|
|
| Fiehn, O. and Spranger, J. Can metabolomics be used for assessing nutritive-dependent human diseases? Phytochem Rev 1(2):223-230 (2002) | ||
| Grossmann, C. Search for a Selective Inhibitor of the 11ß-Hydroxysteroid-Dehydrogenase-1. Dissertation Charité 2002 |
|
|
| Kopp, R., Ruge, M., Rothbauer, E., Cramer, C., Kraemling, H. J., Wiebeck, B., Schildberg, F. W., and Pfeiffer, A. Impact of epidermal growth factor (EGF) radioreceptor analysis on long-term survival of gastric cancer patients. Anticancer Res. 22(2B):1161-1167 (2002) |
|
|
| Möhlig, M., Wegewitz, U., Osterhoff, M., Isken, F., Ristow, M., Pfeiffer, A. F., and Spranger, J. Insulin decreases human adiponectin plasma levels. Horm.Metab Res 34(11-12):655-658 (2002) |
|
|
| Möhlig, M., Spranger, J., Otto, B., Ristow, M., Tschop, M., and Pfeiffer, A. F. Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans. J Endocrinol Invest 25(11):RC36-RC38 (2002) |
|
|
| Oelkers, W. The renin-aldosterone system and drospirenone. Gynecol.Endocrinol. 16(1):83-87 (2002) |
|
|
| Oelkers, W. Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone. Eur.J Contracept.Reprod.Health Care 7 Suppl 3:19-26; discussion 42-3.:19-26 (2002) |
|
|
| Quinkler, M., Meyer, B., Bumke-Vogt, C., Grossmann, C., Gruber, U., Oelkers, W., Diederich, S., and Bähr, V. Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor. Eur.J.Endocrinol. 146(6):789-799 (2002) |
|
|
| Quinkler, M. and Diederich, S. Difference of in vivo and in vitro antimineralocorticoid potency of progesterone. Endocr Res 28(4):465-470 (2002) |
|
|
| Quinkler, M., Lepenies, J., and Diederich, S. Primary hyperaldosteronism. Exp Clin Endocrinol Diabetes 110(6):263-271 (2002) |
|
|
| Schiemann, U., Konturek, J., Assert, R., Rembiasz, K., Domschke, W., Konturek, S., and Pfeiffer, A. mRNA expression of EGF receptor ligands in atrophic gastritis before and after Helicobacter pylori eradication. Med.Sci.Monit. 8(2):CR53-CR58 (2002) |
|
|
| Schöfl, C., Horn, R., Schill, T., Schlosser, H. W., Muller, M. J., and Brabant, G. Circulating ghrelin levels in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 87(10):4607-4610 (2002) |
|
|
| Schöfl, C., Schleth, A., Berger, D., Terkamp, C., von zur, Muhlen A., and Brabant, G. Sympathoadrenal counterregulation in patients with hypothalamic craniopharyngioma. J Clin Endocrinol Metab 87(2):624-629 (2002) |
|
|
| Schöfl, C., Waring, M., Bergwitz, C., Arseniev, L., von zur, Muhlen A., and Brabant, G. Cyclic-adenosine 3',5'-monophosphate-stimulated c-fos gene transcription involves distinct calcium pathways in single beta-cells. Mol.Cell Endocrinol 186(1):121-131 (2002) |
|
|
| Schöfl, C., Schöfl-Siegert, B., Karstens, J. H., Bremer, M., Lenarz, T., Cuarezma, J. S., Samii, M., von zur, Muhlen A., and Brabant, G. Falsely low serum prolactin in two cases of invasive macroprolactinoma. Pituitary. 5(4):261-265 (2002) |
|
|
| Shoichet, S. A., Baumer, A. T., Stamenkovic, D., Sauer, H., Pfeiffer, A. F., Kahn, C. R., Muller-Wieland, D., Richter, C., and Ristow, M. Frataxin promotes antioxidant defense in a thiol-dependent manner resulting in diminished malignant transformation in vitro. Hum Mol Genet 11(7):815-821 (2002) |
|
|
| Troeger, H. Effect of ACTH on cortisol metabolism and characterization of 11ß-hydroxysteroid dehydrogenase isoforms in different tissues of the guinea pig Dissertation Charité 2002 |
|
|
| Ziemssen, F., Bellanne-Chantelot, C., Osterhoff, M., Schatz, H., and Pfeiffer, A. F. To: Lindner T, Cockburn BN, Bell GI (1999). Molecular genetics of MODY in Germany. Diabetologia 42: 121-123. Diabetologia 45(2):286-287 (2002) |
|
|
| 2001 | ||
| Behre, A., Janott, J., Pfohl, M., Schatz, H., and Pfeiffer, A. [Clinical value of urinary pyridinium crosslinks as osteoporosis markers: evaluation of a population survey of vertebral osteoporosis]. Med.Klin. 96(7):378-382 (2001) |
|
|
| Diederich, S., Eckmanns, T., Exner, P., Al Saadi, N., Bähr, V., and Oelkers, W. Differential diagnosis of polyuric/polydipsic syndromes with the aid of urinary vasopressin measurement in adults. Clin.Endocrinol.(Oxf) 54(5):665-671 (2001) |
|
|
| Hering, S., Isken, F., Janott, J., Jost, C., Pommer, A., Muhr, G., Schatz, H., and Pfeiffer, A. F. Analysis of TGFbeta3 gene expression and protein levels in human bone and serum. Exp Clin Endocrinol Diabetes 109(2):107-115 (2001) |
|
|
| Laer, L., Kloppstech, M., Schofl, C., Sejnowski, T. J., Brabant, G., and Prank, K. Noise enhanced hormonal signal transduction through intracellular calcium oscillations. Biophys.Chem. 91(2):157-166 (2001) |
|
|
| Oelkers, W., Diederich, S., and Bähr, V. Therapeutic strategies in adrenal insufficiency. Ann Endocrinol.Paris 62(2):212-216 (2001) |
|
|
| Oelkers, W. and Tuchelt, H. Hypothalamo-pituitary-adrenal axis testing: nothing is sacred and caution in interpretation is needed. Clin.Endocrinol.(Oxf) 55(6):821-822 (2001) |
|
|
| Quinkler, M., Oelkers, W., and Diederich, S. Clinical implications of glucocorticoid metabolism by 11beta-hydroxysteroid dehydrogenases in target tissues. Eur.J.Endocrinol. 144(2):87-97 (2001) |
|
|
| Quinkler, M., Johanssen, S., Bumke-Vogt, C., Oelkers, W., Bähr, V., and Diederich, S. Enzyme-mediated protection of the mineralocorticoid receptor against progesterone in the human kidney. Mol.Cell Endocrinol. 171(1-2):21-24 (2001) |
|
|
| Schiemann, U., Konturek, J. W., Osterhoff, M., Assert, R., Rembiasz, K., Pfeiffer, D., Schatz, H., Domschke, W., and Pfeiffer, A. Decreased expression of epidermal growth factor receptor and mRNA of its ligands in Helicobacter pylori-infected gastric mucosa. Scand.J Gastroenterol. 36(1):23-31 (2001) |
|
|
| Schöfl-Siegert, B., Brabant, G., von zur, Muhlen A., and Schöfl, C. [Reversible blindness caused by an invasive prolactinoma]. Dtsch.Med.Wochenschr. 126(21):621-624 (2001) |
|
|
| Spranger, J., Möhlig, M., Osterhoff, M., Buhnen, J., Blum, W. F., and Pfeiffer, A. F. Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation? Horm Metab Res 33(5):312-316 (2001) |
|
|
| Spranger, J. and Pfeiffer, A. F. New concepts in pathogenesis and treatment of diabetic retinopathy. Exp Clin Endocrinol Diabetes 109 Suppl 2:S438-S450 (2001) |
|
|
| Spranger, J., Osterhoff, M., Reimann, M., Möhlig, M., Ristow, M., Francis, M. K., Cristofalo, V., Hammes, H. P., Smith, G., Boulton, M., and Pfeiffer, A. F. Loss of the Antiangiogenic Pigment Epithelium-Derived Factor in Patients With Angiogenic Eye Disease. Diabetes 50(12):2641-2645 (2001) |
|
|
| Ziemssen, F., Schnepf, R., and Pfeiffer, A. SSCP (single strand conformation polymorphism) analysis for detection of point mutations. A technique and its limits exemplified by dominantly inherited forms of diabetes (MODY). Med.Klin. 96(9):515-520 (2001) |
|
|
| 2000 | ||
| Bumke-Vogt, C., Quinkler, M., Gruber, U., Hermann, S., Oelkers, W., Diederich, S., and Bähr, V. Progesterone receptor expression in human female kidney Vortrag, 44.Symposium der Deutschen Ges.für Endokrinologie in München. Exp Clin Endocrinol Diabetes 108(Suppl1):S1(2000) | ||
| Bumke-Vogt, C., Quinkler, M., Gruber, U., Herrmann, S., Diederich, S., Oelkers, W., and Bähr, V. Progesterone receptor isoform B (hPR-B) in the human kidney 82nd Annual Meeting der Endocrine Society, Toronto, 21.-24.6.2000 Abstract book Nr, 2316, page 555. Kongreß (2000) | ||
| Diederich, S., Grossmann, C., Hanke, B., Quinkler, M., Herrmann, M., Bähr, V., and Oelkers, W. In the search for specific inhibitors of human 11beta-hydroxysteroid-dehydrogenases (11beta-HSDs): chenodeoxycholic acid selectively inhibits 11beta-HSD-I. Eur.J.Endocrinol. 142(2):200-207 (2000) |
|
|
| Diederich, S., Quinkler, M., Burkhardt, P., Großmann, C., Bähr, V., and Oelkers, W. 11beta-Hydroxysteroid-dehydrogenase isoforms: tissue distribution and implications for clinical medicine. Eur.J Clin.Invest 30(S3):21-27 (2000) |
|
|
| Fahrmann, M. and Pfeiffer, A. Copurification of two holoenzyme-forming Calcium/Calmodulin-dependent protein kinase II isoforms as holoenzyme from porcine stomach. Arch.Biochem.Biophys. 380(1):151-158 (2000) |
|
|
| Großmann, C., Hanke, B., Bähr, V., Oelkers, W., and Diederich, S. Selective inhibition of 11ß-hydroxysteroiddehydrogenase type 1 Vortrag, 44.Symposium der Deutschen Ges.für Endokrinologie in München. Exp Clin Endocrinol Diabetes 108(Suppl.1):S55(2000) | ||
| Hellmich, B., Schellner, M., Schatz, H., and Pfeiffer, A. Activation of transforming growth factor-beta1 in diabetic kidney disease. Metabolism 49(3):353-359 (2000) |
|
|
| Horn, P. A., Mohlig, M., Osterhoff, M., Wolter, S., Hofmann, J., Stocking, C., Ostertag, W., Wahl, M., Schatz, H., and Pfeiffer, A. Effect of estradiol on insulin secreting INS-1 cells overexpressing estrogen receptors. Eur.J.Endocrinol. 142(1):84-91 (2000) |
|
|
| Jordan, J., Toka, H. R., Heusser, K., Toka, O., Shannon, J. R., Tank, J., Diedrich, A., Stabroth, C., Stoffels, M., Naraghi, R., Oelkers, W., Schuster, H., Schobel, H. P., Haller, H., and Luft, F. C. Severely impaired baroreflex-buffering in patients with monogenic hypertension and neurovascular contact. Circulation 102(21):2611-2618 (2000) |
|
|
| Meyer, B., Quinkler, M., Gruber, U., Oelkers, W., Diederich, S., and Bähr, V. Human mineralocorticoid receptor (hMC-R) agonist and antagonistic activity of progesterone (P) metabolites Vortrag, 44.Symposium der Deutschen Ges.für Endokrinologie in München. Exp Clin Endocrinol Diabetes 108(Suppl.1):S1(2000) | ||
| Meyer, M. F., Gerresheim, F., Pfeiffer, A., Epplen, J. T., and Schatz, H. Association of polycystic ovary syndrome with an interstitial deletion of the long arm of chromosome 11.[In Process Citation]. Exp Clin Endocrinol Diabetes 108(8):519-523 (2000) |
|
|
| Oelkers, W., Diederich, S., and Bähr, V. Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage. J.Clin.Endocrinol.Metab 85(9):3266-3270 (2000) |
|
|
| Oelkers, W. Drospirenone--a new progestogen with antimineralocorticoid activity, resembling natural progesterone. Eur.J Contracept.Reprod.Health Care 5 Suppl 3:17-24 (2000) |
|
|
| Oelkers, W., Helmerhorst, F. M., Wuttke, W., and Heithecker, R. Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers. Gynecol.Endocrinol. 14(3):204-213 (2000) |
|
|
| Oelkers, W. Meet the Expert: Endocrine Hypertonie 44.Symposium der Deutschen Ges.für Endokrinologie in München. Kongreß (2000) | ||
| Oelkers, W. Clinical diagnosis of hyper- and hypocortisolism. Noise.Health 2(7):39-48 (2000) |
|
|
| Papageorgiou, T. C., Prekumlar, A., et al., Oelkers, W., et al., and Stratakis, C. A. Ovarian Tumors in patients with the "complex of spotty skin pigmementation, mycomes, endocrine averativity and schwanneomas" (Carney Complex): Clinical and genetic studies and evidence of predisposition to cancer 82nd Annual Meeting der Endocrine Society, Toronto, 21.-24.6.2000 Abstract book Nr, 2316, page 559. Kongreß (2000) | ||
| Pfohl, M., Pfeiffer, A., and Schatz, H. Spot glucose measurement in epidermal interstitial fluid--an alternative to capillary blood glucose estimation? Exp Clin Endocrinol Diabetes 108(1):1-4 (2000) |
|
|
| Quinkler, M., Bumke-Vogt, C., Johanssen, S., Herrmann, S., Diederich, S., Oelkers, W., and Bähr, V. Idenification of progesterone metabolizing enzymes in human kidney International workshop: Recent Progess in Research on 17-hydroxysteroid-Dehydrogenases. Schloss Elmau, 4.-8.April 2000. Kongreß (2000) | ||
| Quinkler, M., Bumke-Vogt, C., Johanssen, S., Gruber, U., Hermann, S., Bähr, V., Oelkers, W., and Diederich, S. Progesterone metabolizing enzymes in female human kidney Poster, 44.Symposium der Deutschen Ges.für Endokrinologie in München. Exp Clin Endocrinol Diabetes 108(Suppl1):S172(2000) | ||
| Quinkler, M., Bumke-Vogt, C., Meyer, B., Bähr, V., Oelkers, W., and Diederich, S. Progesterone metabolism and its enzymes in CV-1 cell line Poster, 44.Symposium der Deutschen Ges.für Endokrinologie in München. Exp Clin Endocrinol Diabetes 108(Suppl1):S172(2000) | ||
| Quinkler, M., Oelkers, W., and Diederich, S. In Vivo Measurement of Renal 11ß-Hydroxysteroid Dehydrogenase Type 2 Activity. J.Clin.Endocrinol.Metab 85(12):4921-4922 (2000) |
|
|
| Quinkler, M., Bumke-Vogt, C., Johanssen, S., Meyer, B., Gruber, U., Herrmann, S., Bähr, V., Diederich, S., and Oelkers, W. Progesterone metabolizing enzymes in the human kidney 82nd Annual Meeting der Endocrine Society, Toronto, 21.-24.6.2000. Abstract book Nr, 2316, page 552. Kongreß (2000) | ||
| Schöfl, C., Borger, J., Mader, T., Waring, M., von zur, Muhlen A., and Brabant, G. Tolbutamide and diazoxide modulate phospholipase C-linked Ca(2+) signaling and insulin secretion in beta-cells. Am.J Physiol Endocrinol Metab 278(4):E639-E647 (2000) |
|
|
| Schöfl, C., Borger, J., Lange, S., von zur, Muhlen A., and Brabant, G. Energetic requirement of carbachol-induced Ca2+ signaling in single mouse beta-cells. Endocrinology 141(11):4065-4071 (2000) |
|
|
| Schuppert, F., Berger, D., Peters, H., Schroder, S., Schöfl, C., Tischler, J., Hiller, W. F., and von zur, Muhlen A. [A young woman with neurofibromatosis 1 (Recklinghausen disease), abdominal tumor and hypertension]. Dtsch.Med.Wochenschr. 125(46):1390-1394 (2000) |
|
|
| Spranger, J., Hammes, H. P., Preissner, K. T., Schatz, H., and Pfeiffer, A. F. Release of the angiogenesis inhibitor angiostatin in patients with proliferative diabetic retinopathy: association with retinal photocoagulation. Diabetologia 43(11):1404-1407 (2000) |
|
|
| Spranger, J., Buhnen, J., Jansen, V., Krieg, M., Meyer-Schwickerath, R., Blum, W. F., Schatz, H., and Pfeiffer, A. F. H. Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy. Horm Metab Res 32(5):196-200 (2000) |
|
|
| Tröger, H., Quinkler, M., Stiglic, A., Bähr, V., Oelkers, W., and Diederich, S. The role of 11beta-hydroxysteroid dehydrogenase type 1 (HSD1) in stress adaption of the guinea pig Poster, 44.Symposium der Deutschen Ges.für Endokrinologie in München. Exp Clin Endocrinol Diabetes 108(Suppl1):S91(2000) | ||
| Tuchelt, H., Dekker, K., Bähr, V., and Oelkers, W. Dose-response relationship between plasma ACTH and serum cortisol in the insulin-hypoglycaemia test in 25 healthy subjects and 109 patients with pituitary disease. Clin.Endocrinol.(Oxf) 53(3):301-307 (2000) |
|
|
| Tuchelt, H., Dekker, K., Bähr, V., and Oelkers, W. Normative values for ACTH and cortisol responses in the Insulin - Hypoglyycemia Test, and results in 109 pituitary patients Vortrag, 44.Symposium der Deutschen Ges.für Endokrinologie in München. Exp Clin Endocrinol Diabetes 108(Suppl.1):S43(2000) | ||
| Weigert, C., Sauer, U., Brodbeck, K., Pfeiffer, A., Haring, H. U., and Schleicher, E. D. AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-beta1 promoter in mesangial cells [In Process Citation]. J Am Soc.Nephrol. 11(11):2007-2016 (2000) |
|
|
| 1999 | ||
| Assert, R., Kotter, R., Bisping, G., Scheppach, W., Stahlnecker, E., Muller, K. M., Dusel, G., Schatz, H., and Pfeiffer, A. Anti-proliferative activity of protein kinase C in apical compartments of human colonic crypts: evidence for a less activated protein kinase C in small adenomas. Int.J Cancer 80(1):47-53 (1999) | ||
| Burkhardt, B., Hanke, B., Bähr, B., Oelkers, W., and Diederich, S. Human 11beta-hydroxysteroid-dehydrogenase and their metabolism of synthetic glucocorticoids. Exp Clin Endocrinol Diabetes 107 (Suppl):S23(1999) | ||
| Diederich, S., Quinkler, M., Hanke, B., Bähr, V., and Oelkers, W. [11 beta-hydroxysteroid dehydrogenases: key enzymes in the action of mineralocorticoids and glucocorticoids]. Dtsch.Med.Wochenschr. 124(3):51-55 (1999) | ||
| Diederich, S. Endokrine Hypertonie. 157(1999) | ||
| Fährmann, M., Jacob, P., Seidler, U., Osterhoff, M., Möhlig, M., and Pfeiffer, A. Ca2+/calmodulin-dependent protein kinase II isoenzymes gamma and delta are both present in H+/K+-ATPase-containing rabbit gastric tubulovesicles. Eur.J Biochem. 266(3):1036-1042 (1999) | ||
| Grossmann, C., Quinkler, M., Bähr, V., Oelkers, W., and Diederich, S. Inhibition of 11beta-hydroxysteroid dehydrogenase type II by progesterone and its metabolites in the human kidney. Exp Clin Endocrinol Diabetes 107(Suppl):S88(1999) | ||
| Oelkers, W. Dehydroepiandrosterone for adrenal insufficiency. N.Engl.J.Med. 341:1073-1074 (1999) | ||
| Oelkers, W. and Bähr, V. Use of ACTH-(1-39) radioimmunoassay to measure ACTH-(1-24) - Response. J.Clin.Endocrinol.Metab 84:825-825 (1999) | ||
| Oelkers, W. Comment on comparison of the low dose short synacthen test (1 mg), the conventional dose short synacthen test (250 mg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J.Clin.Endocrinol.Metab 84:2973-2974 (1999) | ||
| Quinkler, M., Johanssen, S., Grossmann, C., Bähr, V., Muller, M., Oelkers, W., and Diederich, S. Progesterone metabolism in the human kidney and inhibition of 11beta- hydroxysteroid dehydrogenase type 2 by progesterone and its metabolites. J.Clin.Endocrinol.Metab 84(11):4165-4171 (1999) | ||
| Ristow, M., Carlqvist, H., Hebinck, J., Vorgerd, M., Krone, W., Pfeiffer, A., Muller-Wieland, D., and Ostenson, C. G. Deficiency of phosphofructo-1-kinase/muscle subtype in humans is associated with impairment of insulin secretory oscillations. Diabetes 48(8):1557-1561 (1999) | ||
| Ristow, M., Vorgerd, M., Mohlig, M., Schatz, H., and Pfeiffer, A. Insulin resistance and impaired insulin secretion due to phosphofructo-1-kinase-deficiency in humans. J Mol.Med. 77(1):96-103 (1999) | ||
| Schöfl, C., Ponczek, M., Mader, T., Waring, M., Benecke, H., von zur, Muhlen A., Mix, H., Cornberg, M., Boker, K. H., Manns, M. P., and Wagner, S. Regulation of cytosolic free calcium concentration by extracellular nucleotides in human hepatocytes. Am.J Physiol 276(1 Pt 1):G164-G172 (1999) | ||
| Schöfl, C., Mader, T., Kramer, C., Waring, M., Krippeit-Drews, P., Prank, K., von zur, Muhlen A., Drews, G., and Brabant, G. Ca2+/calmodulin inhibition and phospholipase C-linked Ca2+ Signaling in clonal beta-cells. Endocrinology 140(12):5516-5523 (1999) | ||
| Spranger, J., Meyer-Schwickerath, R., Klein, M., Schatz, H., and Pfeiffer, A. Deficient activation and different expression of transforming growth factor-beta isoforms in active proliferative diabetic retinopathy and neovascular eye disease. Exp Clin Endocrinol Diabetes 107(1):21-28 (1999) | ||
| 1998 | ||
| al-Saadi, N., Diederich, S., and Oelkers, W. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome. Clin.Endocrinol.(Oxf). 48(1):45-51 (1998) | ||
| Diederich, S., Hanke, B., Burkhardt, P., Müller, M., Schöneshöfer, M., Bähr, V., and Oelkers, W. Metabolism of synthetic corticosteroids by 11b-hydroxysteroid- dehydrogenases in man. Steroids 63:271-277 (1998) | ||
| Fährmann, M., Mohlig, M., Schatz, H., and Pfeiffer, A. Purification and characterization of a Ca2+/calmodulin-dependent protein kinase II from hog gastric mucosa using a protein-protein affinity chromatographic technique [published erratum appears in Eur J Biochem 1998 Oct 1;257(1):291]. Eur.J Biochem. 255(2):516-525 (1998) | ||
| Goodfriend, T. L., Ball, D. L., Oelkers, W., and Bähr, V. Torsemide inhibits aldosterone secretion in vitro. Life Sci. 63:PL45-PL50 (1998) | ||
| Herrmann, B. L., Schatz, H., and Pfeiffer, A. [Continuous blood glucose monitoring: the acute effect of acarbose on blood glucose variations]. Med.Klin. 93(11):651-655 (1998) | ||
| Mayenknecht, J., Diederich, S., Bähr, V., Plöckinger, U., and Oelkers, W. A reevaluation of the low-dose Synacthen test in patients with pituitary disease. Exp Clin Endocrinol Diabetes 106(Suppl):S32(1998) | ||
| Mayenknecht, J., Diederich, S., Bähr, V., Plockinger, U., and Oelkers, W. Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease [In Process Citation]. J.Clin.Endocrinol.Metab 83(5):1558-1562 (1998) | ||
| Oelkers, W. Comparison of low- and high-dose corticotropin stimulation tests in patients with pituitary disease - Author's response. J.Clin.Endocrinol.Metab 83:4532-4533 (1998)Oelkers, W. The role of high- and low-dose corticotropin tests in the diagnosis of secondary adrenal insufficiency. Eur.J.Endocrinol. 139:567-570 (1998) | ||
| Palus, M., Schöfl, C., von zur, Muhlen A., Brabant, G., and Prank, K. Coarse-grained entropy rates quantify fast Ca2+ dynamics modulated by pharmacological stimulation. Pac.Symp.Biocomput. 645-656 (1998) | ||
| Pfeiffer, D., Kimmig, R., Herrmann, J., Ruge, M., Fisseler-Eckhoff, A., Scheidel, P., Jensen, A., Schatz, H., and Pfeiffer, A. Epidermal-growth-factor receptor correlates negatively with cell density in cervical squamous epithelium and is down-regulated in cancers of the human uterus. Int.J Cancer 79(1):49-55 (1998) | ||
| Prank, K., Schöfl, C., Laer, L., Wagner, M., von zur, Muhlen A., Brabant, G., and Gabbiani, F. Coding of time-varying hormonal signals in intracellular calcium spike trains. Pac.Symp.Biocomput. 633-644 (1998) | ||
| Quinkler, M., Bähr, V., Müller, M., Oelkers, W., and Diederich, S. Progesterone metabolism in the human kidney. Exp Clin Endocrinol Diabetes 106(Suppl):S 41(1998) | ||
| Ristow, M., Muller-Wieland, D., Pfeiffer, A., Krone, W., and Kahn, C. R. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N.Engl.J.Med. 339(14):953-959 (1998) | ||
| Ristow, M., Giannakidou, E., Hebinck, J., Busch, K., Vorgerd, M., Kotzka, J., Knebel, B., Mueller-Berghaus, J., Epplen, C., Pfeiffer, A., Kahn, C. R., Doria, A., Krone, W., and Mueller-Wieland, D. An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene. Diabetes 47(5):851-854 (1998) | ||
| Tietge, U. J., Schöfl, C., Ocran, K. W., Wagner, S., Boker, K. H., Brabant, G., Zapf, J., and Manns, M. P. Hepatoma with severe non-islet cell tumor hypoglycemia. Am.J Gastroenterol. 93(6):997-1000 (1998) | ||
| 1997 | ||
| Diederich, S., Hanke, B., Oelkers, W., and Bähr, V. Metabolism of dexamethasone in the human kidney: Nicotinamide adenine dinucleotide-dependent 11b-reduction. J.Clin.Endocrinol.Metab 82:1598-1602 (1997) | ||
| Diederich, S., Hanke, B., Bähr, V., and Oelkers, W. The dogma of unidirectional 11beta-Hydroxysteroid-Dehydrogenase-II is incorrect: 11beta-reduction of 11-dehydro-dexamethasone in the human kidney. Exp Clin Endocrinol Diabetes 105(Suppl. 1):v041(1997) | ||
| Hanke, B., Diederich, S., Bähr, V., and Oelkers, W. Characterization of human hepatic 11beta-Hydroxysteroid-Dehydrogenase type I. Exp Clin Endocrinol Diabetes 105(Suppl. 1):p068(1997) | ||
| Hensen, J., Seufferlein, T., and Oelkers, W. Atherosclerosis, aortic stenosis and sudden onset central diabetes insipidus. Exp Clin Endocrinol Diabetes 105:227-233 (1997) | ||
| Hensen, J. and Oelkers, W. [Mineralocorticoid-induced hypertension]. Med Klin. 92(5):273-278 (1997) | ||
| Möhlig, M., Wolter, S., Mayer, P., Lang, J., Osterhoff, M., Horn, P. A., Schatz, H., and Pfeiffer, A. Insulinoma cells contain an isoform of Ca2+/calmodulin-dependent protein kinase II delta associated with insulin secretion vesicles. Endocrinology 138(6):2577-2584 (1997) | ||
| Pfeiffer, A. [1997 diabetes update]. Med.Klin. 92(11):655-662 (1997) | ||
| Pfeiffer, A., Spranger, J., Meyer-Schwickerath, R., and Schatz, H. Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown. Diabetes 46 Suppl 2:S26-S30 (1997) | ||
| Pfeiffer, A., Janott, J., Mohlig, M., Ristow, M., Rochlitz, H., Busch, K., Schatz, H., and Schifferdecker, E. Circulating tumor necrosis factor alpha is elevated in male but not in female patients with type II diabetes mellitus. Horm Metab Res 29(3):111-114 (1997) | ||
| Pfeiffer, D., Spranger, J., Al Deiri, M., Kimmig, R., Fisseler-Eckhoff, A., Scheidel, P., Schatz, H., Jensen, A., and Pfeiffer, A. mRNA expression of ligands of the epidermal-growth-factor-receptor in the uterus. Int.J Cancer 72(4):581-586 (1997) | ||
| Quinkler, M., Kosmale, B., Bähr, V., Oelkers, W., and Diederich, S. Evidence for isoforms of 11b-hydroxysteroid dehydrogenase in the liver and kidney of the guinea pig. J Endocrinol. 153:291-298 (1997) | ||
| Ristow, M., Vorgerd, M., Mohlig, M., Schatz, H., and Pfeiffer, A. Deficiency of phosphofructo-1-kinase/muscle subtype in humans impairs insulin secretion and causes insulin resistance. J.Clin.Invest. 100(11):2833-2841 (1997) | ||
| Schiemann, U., Assert, R., Moskopp, D., Gellner, R., Hengst, K., Gullotta, F., Domschke, W., and Pfeiffer, A. Analysis of a protein kinase C-alpha mutation in human pituitary tumours. J Endocrinol. 153(1):131-137 (1997) | ||
| Schöfl, C., Rossig, L., Mader, T., Borger, J., Potter, E., von zur, Muhlen A., and Brabant, G. Impairment of ATP-induced Ca2+ -signalling in human thyroid cancer cells. Mol.Cell Endocrinol 133(1):33-39 (1997) | ||
| Schöfl, C., Becker, C., Prank, K., von zur, Muhlen A., and Brabant, G. Twenty-four-hour rhythms of plasma catecholamines and their relation to cardiovascular parameters in healthy young men. Eur.J Endocrinol 137(6):675-683 (1997) | ||
| Schöfl, C. and von zur, Muhlen A. [Preventing adverse side-effects of glucocorticoid therapy]. Internist (Berl) 38(4):371-378 (1997) | ||
| 1996 | ||
| Assert, R., Schatz, H., and Pfeiffer, A. Upregulation of PKC d. FEBS Lett. 388(2-3):195-199 (1996) | ||
| Bähr, V., Möbius, K., Redmann, A., and Oelkers, W. Ascorbate and a-tocopherol depletion inhibit aldosterone stimulation by sodium deficiency in the guinea pig. Endocr Res 22:595-600 (1996) | ||
| Bülow, H. E., Möbius, K., Bähr, V., and Bernhardt, R. Molecular cloning and functional expression of the cytochrome p450 11B-hydroxylase of the guinea pig. Biochem.Biophys.Res.Comm. 221:304-312 (1996) | ||
| Bülow, H. E., Möbius, K., Bähr, V., and Bernhardt, R. Functional expression of the guinea pig 11b-hydroxylase in COS-1 cells. Endocr Res 22:479-484 (1996) | ||
| Diederich, S., Quinkler, M., Miller, K., Heilmann, P., Schoeneshofer, M., and Oelkers, W. Human kidney 11Beta-hydroxysteroid dehydrogenase: Regulation by adrenocorticotropin? Eur.J.Endocrinol. 134(3):301-307 (1996) | ||
| Diederich, S., Quinkler, M., Möbius, K., Heilmann, P., Schöneshöfer, M., and Oelkers, W. Effects of ACTH on renal and hepatic 11beta-hydroxysteroid-dehydrogenase in the guinea pig. Exp Clin Endocrinol Diabetes 104 (Suppl.1):112(1996) | ||
| Diederich, S., Hanke, B., Bähr, V., and Oelkers, W. The metabolism of 9a-fluorinated steroids in the human kidney. Endocr Res 22:803-810 (1996) | ||
| l'Allemand, D., Penhoat, A., Lebrethon, M. C., Ardèvol, R., Bähr, V., Oelkers, W., and Saez, J. M. Insulin-like growth factors enhance steroidogenic enzyme and corticotropin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells. J.Clin.Endocrinol.Metab 81:3892-3897 (1996) | ||
| Möbius, K., Redmann, A., Hiller, H. H., Oelkers, W., and Bähr, V. Permissive role of a-tocopherol in the stimulation of aldosterone by sodium depletion in the guinea pig. Eur.J.Endocrinol. 134:758-763 (1996) | ||
| Möhlig, M., Ristow, M., Rifai, M., Schatz, H., Feldmann, K., and Pfeiffer, A. [Mutation des InhA-Gens bei Mycobacterium tuberculosis resistent gegen Isoniazid/ Ethionamid]. Atemwegs- und Lungenkrankheiten 8:419(1996) | ||
| Oelkers, W. Adrenal insufficiency. New England.Journal.of.Medicine 335(16):1206-1212 (1996) | ||
| Oelkers, W. Dose-response aspects in the clinical assessment of the hypothalamopituitary-adrenal axis, and the low-dose adrenocorticotropin test. Eur.J.Endocrinol. 135:27-33 (1996) | ||
| Pfeiffer, A., Middelberg-Bisping, K., Drewes, C., and Schatz, H. Elevated plasma levels of transforming growth factor-beta 1 in NIDDM. Diabetes Care 19(10):1113-1117 (1996) | ||
| Pfeiffer, A. Diabetes: many leads to PKC (protein kinase C) [comment]. Exp Clin Endocrinol Diabetes 104(1):17-18 (1996) | ||
| Pirags, V., Assert, R., Haupt, K., Schatz, H., and Pfeiffer, A. Activation of human platelet protein kinase C-beta 2 in vivo in response to acute hyperglycemia. Exp Clin Endocrinol Diabetes 104(6):431-440 (1996) | ||
| Ristow, M., Schatz, H., Hollt, V., and Pfeiffer, A. Widespread expression of a new putative hormone extrusion pump: NG-TRA transporter protein in human and rat tissue. Horm Metab Res 28(3):138-141 (1996) | ||
| Ristow, M., Busch, K., Schatz, H., and Pfeiffer, A. Restricted geographical extension of the association of a glucagon receptor gene mutation (Gly40Ser) with non-insulin-dependent diabetes mellitus. Diabetes Res.Clin.Pract. 32(3):183-185 (1996) | ||
| Schöfl, C., Rossig, L., Leitolf, H., Mader, T., von zur, Mühlen A., and Brabant, G. Generation of repetitive Ca2+ transients by bombesin requires intracellular release and influx of Ca2+ through voltage-dependent and voltage independent channels in single HIT cells. Cell Calcium 19(6):485-493 (1996) | ||
| Schöfl, C., Rossig, L., Mader, T., von zur, Mühlen A., and Brabant, G. CYCLIC adenosine 3',5'-monophosphate potentiates Ca2+ signaling and insulin secretion by phospholipase C-linked hormones in HIT cells. Endocrinology 137(7):3026-3032 (1996) | ||
| Schubert, S., Andresen, B. H., Bähr, V., Fischer, L., Stamp, R., Stricker, G., Wittke, J. W., and Ullmann, U. The immunomodulatory effects of antibiotics: in vitro and ex vivo investigations of 21 substances by means of the lymphocyte transformation test. Zentralbl.Bakteriol. 284(2-3):402-438 (1996) | ||
| Schuster, H., Wienker, T. F., Toka, H. R., Bähring, S., Jeschke, E., Toka, O., Busjahn, A., Hempel, A., Tahlhammer, C., Oelkers, W., Kunze, J., Bilginturan, N., Haller, H., and Luft, F. C. Autosomal dominant hypertension and brachydactyly in a Turkish kindred resembles essential hypertension. Journal.of.Biological.Chemistry. 28:1085-1092 (1996) | ||
| Steffgen, J., Ehrhart-Bornstein, M., Bähr, V., Herkommer, B., Sippell, W. G., Güse-Behling, H., Franz, H. E., Scherbaum, W. A., and Bornstein, S. R. Evidence for the involvement of an anion exchanger in cortisol release from bovine adrenocortical cells. Cell.Physiol.Biochem. 6:82-90 (1996) | ||
| 1995 | ||
| Bülow, H. F., Möbius, K., Bähr, V., and Bernhardt, R. Molecular Cloning of an Enzyme of the CYP11B Subfamily of the Guinea Pig. 9tht International Conference on Cytochrome P450 Enzymes, Zürich (1995) | ||
| Diederich, S., Quinkler, M., Miller, K., Heilmann, P., Schöneshöfer, M., and Oelkers, W. Effects of ACTH on renal and hepatic 11-hydroxysteroid-dehydrogenase. 77th Annual Meeting (Washington D.C.), Endocrine Society [abstract]:337(1995) | ||
| Erdmann, B., Gerst, H., Bülow, H., Lenz, D., Bähr, V., and Bernhardt, R. Zone-specific localization of cytochrome P45011B1 in human adrenal tissue by PCR-derived riboprobes. Histochem.Cell Biol. 104:301-307 (1995) | ||
| l'Allemand, D., Lebrethon, M. C., Penhoat, A., Ardévol, R., Bähr, V., and Saez, M. J. Insulin-like growth factors inhance the mRNA-expression of steroidogenic enzymes and of the ACTH-receptor in adul human adrenocortical cells in culture. Exp Clin Endocrinol 103, Suppl. 1:66(1995) | ||
| Mayer, P., Möhlig, M., Idlibe, D., and Pfeiffer, A. Novel and uncommon isoforms of the calcium sensing enzyme calcium/calmodulin dependent protein kinase II in heart tissue. Basic Res Cardiol. 90(5):372-379 (1995) | ||
| Möhlig, M., Mayer, P., Horn, P. A., Schatz, H., and Pfeiffer, A. Overexpression of calcium/calmodulin-dependent protein kinase II in insulinoma cells by use of a retroviral vector. Exp.Clin Endocrinol Diabetes 103 Suppl 2:71-73 (1995) | ||
| Munte, T. F., Berger, D., Terkamp, C., Schöfl, C., Johannes, S., and Brabant, G. Cognitive functioning in experimental hypoglycaemia assessed with event-related potentials. Neuroreport 6(11):1509-1512 (1995) | ||
| Oelkers, W., Foidart, J. M., Dombrovicz, N., Welter, A., and Heithecker, R. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism. J.Clin.Endocrinol.Metab 80:1816-1821 (1995) | ||
| Oelkers, W. Diagnostic puzzle of the adrenal "incidentaloma" [comment]. Eur.J.Endocrinol. 132(4):419-421 (1995) | ||
| Quinkler, M., Diederich, S., and Oelkers, W. Regulation of renal 11beta-hydroxysteroid-dehydrogenase by ACTH ? Exp Clin Endocrinol Diabetes 103 (Suppl. 1):128(1995) | ||
| Redmann, A., Möbius, K., Oelkers, W., and Bähr, V. The influence of ascorbate depletion on aldosterone biothynthesis in guinea pig. Exp Clin Endocrinol 103 Suppl. 1:128(1995) | ||
| Redmann, A., Möbius, K., Hiller, H. H., Oelkers, W., and Bähr, V. Ascorbate depletion prevents aldosterone stimulation by sodium deficiency in the guinea pig. Eur.J.Endocrinol. 133:499-506 (1995) | ||
| Ristow, M., Möhlig, M., Rifai, M., Schatz, H., Feldmann, K., and Pfeiffer, A. New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains. Lancet 346(8973):502-503 (1995) | ||
| Schöfl, C., Schulte, P., Rossig, L., von zur, Muhlen A., and Brabant, G. Vasopressin induces frequency-modulated repetitive calcium transients in single insulin-secreting hit cells. Mol.Cell Endocrinol 108(1-2):185-192 (1995) | ||
| Schöfl, C., Rossig, L., Potter, E., von zur, Muhlen A., and Brabant, G. Extracellular ATP and UTP increase cytosolic free calcium by activating a common P2u-receptor in single human thyrocytes. Biochem.Biophys.Res Commun. 213(3):928-934 (1995) | ||
| Schöfl, C., Rossig, L., von zur, Muhlen A., Beil, W., Jahne, J., Manns, M. P., and Wagner, S. Extracellular nucleotides increase cytosolic free calcium by activating P2u-receptors in single human gastric mucous cells. Biochem.Biophys.Res Commun. 216(2):637-641 (1995) | ||
| Schöfl, C., Prank, K., and Brabant, G. [Pulsatile hormone secretion for control of target organs]. Wien.Med.Wochenschr. 145(17-18):431-435 (1995) | ||
| Schwaninger, M., Schöfl, C., Blume, R., Rossig, L., and Knepel, W. Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription. Mol.Pharmacol. 47(6):1112-1118 (1995) | ||
| Steffgen, J., Herkommer, B., Bähr, V., Sippell, W. G., Haidan, A., and Bornstein, S. R. Evidence for the envolvement of an anion-exchanger in cortisol release from bovine adrenocortical cells. Conference on transport of organic anions and cations across cellular membranes (1995) | ||
| 1993 | ||
| Bähr, V., Sander Bähr, C., Hensen, J., and Oelkers, W. Influence of sodium and potassium diets on adrenal vasopressin content and direct effects of vasopressin on aldosterone synthesis in adrenocortical cells. Horm Metab Res 25(8):411-416 (1993) | ||
| Bähr, V., Sander-Bähr, C., Ardevol, R., Tuchelt, H., Beland, B., and Oelkers, W. Effects of atrial natriuretic factor on the renin-aldosterone system: In vivo and in vitro studies. J.Steroid Biochem.Mol.Biol. 45:173-178 (1993) | ||
| Diederich, S., Buchen, S., Krain, J., Muhme, S., Schöneshöfer, M., and Oelkers, W. Renale 11beta-hydroxysteroid Dehydrogenase: Bedeutung des Enzyms für die mineralocorticoide Potenz von 9-alpha-Fluorocortisol und beim ektopen ACTH-Syndrom. Wissenschaftswoche Univ.-Klinikum Benj.Franklin Berlin 1993 (1993) | ||
| Hensen, J., Buhl, M., and Oelkers, W. The functional spectrum of adrenocortical adenomas. Med.Hypotheses. 40:217-222 (1993) | ||
| Hocher, B., Bähr, V., Dorfmuller, S., and Oelkers, W. Hypercortisolism with non-pigmented micronodular adrenal hyperplasia: transition from pituitary-dependent to adrenal- dependent Cushing's syndrome. Acta Endocrinol.Copenh. 128(2):120-125 (1993) | ||
| Mayer, P., Möhlig, M., Schatz, H., and Pfeiffer, A. New isoforms of multifunctional calcium/calmodulin-dependent protein kinase II. FEBS Lett. 333(3):315-318 (1993) | ||
| Schöfl, C., Brabant, G., Hesch, R. D., von zur, Muhlen A., Cobbold, P. H., and Cuthbertson, K. S. Temporal patterns of alpha 1-receptor stimulation regulate amplitude and frequency of calcium transients. Am.J Physiol 265(4 Pt 1):C1030-C1036 (1993) | ||
| 1992 | ||
| Auernhammer, C. J., Stalla, G. K., Lange, M., Pfeiffer, A., and Muller, O. A. Effects of loperamide on the human hypothalamo-pituitary-adrenal axis in vivo and in vitro. J.Clin.Endocrinol.Metab 75:552-557 (1992) | ||
| Diederich, S., Bähr, V., and Oelkers, W. Guidelines for appropriate dosage of fludrocortisone in Addison's disease. 18th Annual International Aldosterone Conference, San Antonio (1992) | ||
| Hocher, B., Keller, F., Krause, P. H., Gollnick, H., and Oelkers, W. Interstitial nephritis with reversible renal failure due to a copper-containing intrauterine contraceptive device. Nephron 61(1):111-113 (1992) | ||
| Mayer, P., Pfeiffer, A., and Schatz, H. Enzymatic detection of a Ca2+/calmodulin dependent protein kinase in RINm5F cells similar to Ca2+/calmodulin kinase type II. Horm.Metab Res 24(2):95(1992) | ||
| Oelkers, W., Diederich, S., and Bähr, V. Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone. J.Clin.Endocrinol.Metab 75:259-264 (1992) | ||
| Pfeiffer, A. and Schatz, H. Pathophysiological aspects of non-tyrosine kinase signal transduction. Horm.Metab Res 24(5):219-224 (1992) | ||
| Schöfl, C., Cuthbertson, K. S., Walsh, C. A., Mayne, C., Cobbold, P., von zur, Muhlen A., Hesch, R. D., and Gallagher, J. A. Evidence for P2-purinoceptors on human osteoblast-like cells. J Bone Miner.Res 7(5):485-491 (1992) | ||
| Sehested, J., Thomas, F., Thom, M., Schifter, S., Regitz, V., Sheikh, S., Oelkers, W., Palm, U., Meyersabellek, W., and Hetzer, R. Level and Diurnal Variations of Hormones of Interest to the Cardiovascular System in Patients with Heart Transplants. Am.J.Cardiol. 69:397-402 (1992) | ||
| Sharma, A. M., Schattenfroh, S., Thiede, H. M., Oelkers, W., and Distler, A. Effects of sodium salts on pressor reactivity in salt-sensitive men. Hypertension 19(6 Pt 1):541-548 (1992) | ||
| Stalke, J., Hader, O., Bähr, V., Hensen, J., Scherer, G., and Oelkers, W. The role of vasopressin in the nicotine-induced stimulation of ACTH and cortisol in men. Clin Investig. 70(3-4):218-223 (1992) | ||
| 1991 | ||
| Bähr, V., Hensen, J., Hader, O., Bolke, T., and Oelkers, W. Stimulation of steroid secretion by adrenocorticotropin injections and by arginine vasopressin infusions: no evidence for a direct stimulation of the human adrenal by arginine vasopressin. Acta Endocrinol.(Copenh.) 125:348-353 (1991) | ||
| Hensen, J., Dolz, M., and Oelkers, W. [Transient polyuria in pregnancy in diabetes insipidus and gestational diabetes]. Med.Klin.(Munich) 86(12):623-628 (1991) | ||
| Kopp, R., Noelke, B., Sauter, G., Schildberg, F. W., Paumgartner, G., and Pfeiffer, A. Altered protein kinase C activity in biopsies of human colonic adenomas and carcinomas. Cancer Res 51(1):205-210 (1991) | ||
| Oelkers, W. Inappropriate secretion of vasopressin in patients with hypopituitarism. Reply. N.Engl.J.Med.1990;322(8):555-556. -556 (1991) | ||
| Oelkers, W., Diederich, S., and Bähr, V. Diagnosis of Addison's disease by single ACTH, cortisol, PRA and aldosterone measurements and therapy surveillance by PRA monitoring. 73rd Annual Meeting (Washington D.C.), The Endocrine Society :259(1991) | ||
| Oelkers, W., Berger, V., Bolik, A., Bähr, V., Hazard, B., Beier, S., Elger, W., and Heithecker, A. Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women. J.Clin.Endocrinol.Metab 73:837-842 (1991) | ||
| Pfeiffer, A., Kohl, P., Mayer, P., Sauter, G., and Kopp, R. [Second messenger systems in the gastrointestinal tract]. Z.Gastroenterol.Verh. 26:273-277 (1991) | ||
| Schöfl, C., Sanchez-Bueno, A., Brabant, G., Cobbold, P. H., and Cuthbertson, K. S. Frequency and amplitude enhancement of calcium transients by cyclic AMP in hepatocytes. Biochem.J 273 ( Pt 3):799-802 (1991) | ||
| Schöfl, C., Cuthbertson, K. S., Gallagher, J. A., Pennington, S. R., Cobbold, P. H., Brabant, G., Hesch, R. D., and von zur, Muhlen A. Measurement of intracellular Ca2+ in single aequorin-injected and suspensions of fura-2-loaded ROS 17/2.8 cells and normal human osteoblasts. Effect of parathyroid hormone. Biochem.J 274 ( Pt 1):15-20 (1991) | ||
| Spranger, J. Mixed-sclerosing-bone-dystrophy (osteopathia striata and osteopetrosis) and Cushing's syndrome. Bone 12:133-133 (1991) | ||
| 1990 | ||
| Hader, O., Bähr, V., Hensen, J., Hofbauer, K. G., and Oelkers, W. K. Effects of a V1-vasopressin antagonist on ACTH release following vasopressin infusion or insulin-induced hypoglycemia in normal men. Acta Endocrinol.(Copenh.) 123:622-628 (1990) | ||
| Hensen, J., Buhl, M., Bähr, V., and Oelkers, W. Endocrine activity of the "silent" adrenocortical adenoma is uncovered by response to corticotropin-releasing hormone. Klin.Wochenschr. 68:608-614 (1990) | ||
| Oelkers, W. [Hyponatremia]. Dtsch.Med.Wochenschr. 115(45):1720-1723 (1990) | ||
| Oelkers, W. [Endocrinologic viewpoint of arterial hypertension]. Fortschr.Med. 108(11):213-214 (1990) | ||
| Pfeiffer, A., Rochlitz, H., Noelke, B., Tacke, R., Moser, U., Mutschler, E., and Lambrecht, G. Muscarinic receptors mediating acid secretion in isolated rat gastric parietal cells are of M3 type. Gastroenterology 98(1):218-222 (1990) | ||
| Schöfl, C., Sanchez-Bueno, A., Dixon, C. J., Woods, N. M., Lee, J. A., Cuthbertson, K. S., Cobbold, P. H., and Birchall, J. D. Aluminium perturbs oscillatory phosphoinositide-mediated calcium signalling in hormone-stimulated hepatocytes. Biochem.J 269(2):547-550 (1990) | ||
| Tuchelt, H., Eschenhagen, G., Bähr, V., Schwietzer, G., Thiede, H. M., and Oelkers, W. Role of atrial natriuretic factor in changes in the responsiveness of aldosterone to angiotensin II secondary to sodium loading and depletion in man. Clin.Sci. 79:57-65 (1990) | ||
| 1989 | ||
| Oelkers, W. Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism [see comments]. N.Engl.J.Med. 321(8):492-496 (1989) | ||
| Pfeiffer, A., Kopp, R., and Rochlitz, H. Stimulation of inositol phosphate and diacylglycerol production by RHC 80267, a diacylglycerol-lipase inhibitor, in rat gastric parietal cells: effects on hydrogen ion secretion. Biochim.Biophys.Acta 1001(2):191-195 (1989) | ||
| Schöfl, C., Meier, K., Gotz, D. M., and Knepel, W. cAMP- and diacylglycerol-mediated pathways elevate cytosolic free calcium concentration via dihydropyridine-sensitive, omega-conotoxin-insensitive calcium channels in normal rat anterior pituitary cells. Naunyn Schmiedebergs Arch.Pharmacol. 339(1-2):1-7 (1989) | ||
| 1988 | ||
| Bähr, V., Hensen, J., Hader, O., and Oelkers, W. Effects of osmotically stimulated endogenous vasopressin on basal and CRH-stimulated ACTH release in man. Acta Endocrinol.(Copenh.) 117:103-108 (1988) | ||
| Eckhoff, C., Oelkers, W., and Bähr, V. Effects of two oral antimycotics, ketoconazole and fluconazole, upon steroidogenesis in rat adrenal cells in vitro. J.Steroid Biochem. 31(5):819-823 (1988) | ||
| Hensen, J., Bähr, V., and Oelkers, W. [Severe hypernatremia in acquired disorder of thirst and vasopressin regulation]. Klin.Wochenschr. 66:498-501 (1988) | ||
| Hensen, J., Hader, O., Bähr, V., and Oelkers, W. Effects of incremental infusions of arginine vasopressin on adrenocorticotropin and cortisol secretion in man. J.Clin.Endocrinol.Metab 66:668-671 (1988) | ||
| Knepel, W., Schöfl, C., and Gotz, D. M. Arachidonic acid elevates cytosolic free calcium concentration in rat anterior pituitary cells. Naunyn Schmiedebergs Arch.Pharmacol. 338(3):303-309 (1988) | ||
| Knepel, W., Schöfl, C., Wesemeyer, G., and Gotz, D. M. Opioids and cytosolic calcium in rat anterior pituitary: dynorphin preparation showed LHRH-like action due to contamination. Experientia 44(11-12):1003-1005 (1988) | ||
| Meier, K., Knepel, W., and Schöfl, C. Potassium depolarization elevates cytosolic free calcium concentration in rat anterior pituitary cells through 1,4-dihydropyridine-sensitive, omega-conotoxin-insensitive calcium channels. Endocrinology 122(6):2764-2770 (1988) | ||
| Oelkers, W., Kleiner, S., and Bähr, V. Effects of incremental infusions of atrial natriuretic factor on aldosterone renin and blood pressure in humans. Hypertension 12:462-467 (1988) | ||
| Oelkers, W., Boelke, T., and Bähr, V. Dose-response relationships between plasma adrenocorticotropin (ACTH), cortisol, aldosterone, and 18-hydroxycorticosterone after injection of ACTH-(1-39) or human corticotropin-releasing hormone in man. J.Clin.Endocrinol.Metab 66:181-186 (1988) | ||
| Pfeiffer, A., Rochlitz, H., Herz, A., and Paumgartner, G. Stimulation of acid secretion and phosphoinositol production by rat parietal cell muscarinic M2 receptors. Am.J Physiol 254(4 Pt 1):G622-G629 (1988) | ||
| 1987 | ||
| Eggens, U., Bähr, V., and Oelkers, W. Effects of b-lipotropin, b-endorphin, gamma2-melanotropin and corticotropin on steroid production by isolated human adrenocortical cells. J.Clin.Chem.Clin.Biochem. 25:779-783 (1987) | ||
| Eisenschmid, B., Heilmann, P., Oelkers, W., Rejaibi, R., and Schoneshofer, M. 20-Dihydroisomers of cortisol and cortisone in human urine: excretion rates under different physiological conditions. J.Clin.Chem.Clin.Biochem. 25(6):345-349 (1987) | ||
| Haller, H., Bähr, V., Bock, A., Distler, A., and Philipp, T. Vasopressin is increased in mineralocorticoid-induced blood pressure increase in man. J.Hypertens.[Suppl].5.(5).S111-3./1987.Dec/IMD=8807. -3 (1987) | ||
| Hensen, J., Bähr, V., and Hader, O. [Hyponatremia caused by water intoxication]. Dtsch.Med.Wochenschr. 112(31-32):1237-1238 (1987) | ||
| Knepel, W. and Schöfl, C. Intracellular free calcium concentration in rat anterior pituitary cells as indicated by fura-2: effect of arginine- vasopressin. Naunyn Schmiedebergs Arch.Pharmacol. 336(3):321-326 (1987) | ||
| Oelkers, W. and Bähr, V. Effects of fludrocortisone withdrawal on plasma angiotensin II, ACTH, vasopressin, and potassium in patients with Addison's disease. Acta Endocrinol.Copenh. 115(3):325-330 (1987) | ||
| Pfeiffer, A., Sauter, G., and Rochlitz, H. Functional and biochemical interaction of dibutyryl cyclic AMP with the phosphoinositide system in isolated rat parietal cells. Biochem.Biophys.Res Commun. 147(2):758-764 (1987) | ||
| Schöfl, C., Sandow, J., and Knepel, W. GRF elevates cytosolic free calcium concentration in rat anterior pituitary cells. Am.J Physiol 253(5 Pt 1):E591-E594 (1987) | ||
| 1986 | ||
| Bogner, U., Eggens, U., Hensen, J., and Oelkers, W. Incidentally discovered ACTH-dependent adrenal adenoma presenting as 'pre-Cushing's syndrome'. Acta Endocrinol.(Copenh.) 111:89-92 (1986) | ||
| Haller, H., Hensen, J., Bähr, V., and Oelkers, W. Effects of angiotensin II infusion on the early morning surge of ACTH and o-CRH-provoked ACTH secretion in normal man. Acta Endocrinol.(Copenh.) 112(2):150-156 (1986) | ||
| Oelkers, W., Bähr, V., Hensen, J., and Pickartz, H. Primary adrenocortical micronodular adenomatosis causing Cushing's syndrome. Effects of ketoconazole on steroid production and in vitro performance of adrenal cells. Acta Endocrinol.Copenh. 113(3):370-377 (1986) | ||
| Pfeiffer, A., Knepel, W., Braun, S., Meyer, H. D., Lohmann, H., and Brantl, V. Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man. Horm Metab Res 18:842-848 (1986) | ||
| Schoneshofer, M., Weber, B., Oelkers, W., Nahoul, K., and Mantero, F. Measurement of urinary free 20 alpha-dihydrocortisol in biochemical diagnosis of chronic hypercorticoidism. Clin.Chem. 32(5):808-810 (1986) | ||
| Schoneshofer, M., Weber, B., Oelkers, W., Nahoul, K., and Mantero, F. Urinary excretion rates of 15 free steroids: potential utility in differential diagnosis of Cushing's syndrome. Clin.Chem. 32(1 Pt 1):93-96 (1986) | ||
| 1985 | ||
| Achenbach, K. and Oelkers, W. Comparison of insulin hypoglycemia and short metyrapone tests in patients with pituitary disease. Klin.Wochenschr. 63:769-774 (1985) | ||
| Haller, H., Bähr, V., Exner, P., and Oelkers, W. Effect of angiotensin II on plasma ACTH in patients with Addison's disease. Acta Endocrinol.(Copenh.) 110:451-455 (1985) | ||
| Oelkers, W. Prolonged ACTH infusion suppresses aldosterone secretion in spite of high renin activity. Acta Endocrinol.Copenh. 108(1):91-97 (1985) | ||
| Schwietzer, G., Laass, C., Kampf, D., Bähr, V., Schultze, G., Molzahn, M., and Distler, A. Does captopril reduce renal function in renovascular disease by postglomerular vasodilatation? J Hypertens.Suppl 3(2):S139-S141 (1985)6667682 | ||
| 1984 | ||
| Wiederholt, M., Hampel, J., Belkien, L., and Oelkers, W. Aldosterone secretion, measurements of membrane potential and intracellular potassium activity in the isolated adrenal zone glomerulosa. FEBS Lett. 174(2):211-214 (1984) | ||
| 1983 | ||
| Bähr, V. and Ullmann, U. The influence of metronidazole and its two main metabolites on murine in vitro lymphocyte transformation. Eur.J Clin.Microbiol. 2(6):568-570 (1983) | ||
| Belkien, L., Baumann, J., Schirpai, M., and Oelkers, W. Propranolol enhances the effect of ACTH on plasma cortisol, but not on aldosterone in man. J.Endocrinol.Invest. 6(5):341-345 (1983) | ||
| Belkien, L., Exner, P., and Oelkers, W. Active and inactive renin in primary and secondary adrenal insufficiency and during ACTH infusion. Acta Endocrinol (Copenh) 102(2):265-270 (1983) | ||
| Belmega, W., Oelkers, W., Belkien, L., Shirpai, M., Fiedler, U., and Haring, R. Effects of angiotensin II and ACTH on normal and tumourous human adrenocortical cells. Acta Endocrinol.(Copenh.) 104:103-109 (1983) | ||
| Fromm, M., Oelkers, W., and Hegel, U. Time course of aldosterone and corticosterone plasma levels in rats during general anaesthesia and abdominal surgery. Pflugers Arch. 399(4):249-254 (1983) | ||
| 1982 | ||
| Bähr, V. and Hänsel, R. Immunomodulating properties of 5,20 alpha (R)-dihydroxy-6 alpha,7 alpha-epoxy-1-oxo-(5 alpha)-whitha-2,24-dienolide and solasodine. Planta Med. 44(1):32-33 (1982) | ||
| Oelkers, W., Belkien, L., Baumann, J., and Meyland, M. The effect of captopril on renin, angiotensin II, cortisol and aldosterone during ACTH-infusion in man. Clin Exp.Hypertens.A 4(9-10):1505-1517 (1982) | ||
| Oelkers, W., Kohler, A., Belkien, L., Fuchs-Hammoser, R., Maiga, M., Scherer, B., and Weber, P. C. Studies on the mechanism by which ACTH stimulates renin activity and angiotensin II formation in man. Acta Endocrinol (Copenh) 100(4):573-580 (1982) | ||
| Schwietzer, G. and Oelkers, W. The antihypertensive effect of captopril in severe essential, renovascular, renal and transplant renovascular hypertension. Klin.Wochenschr. 60(16):839-846 (1982) | ||
| 1981 | ||
| Oelkers, W., Kohler, A., Belkien, L., Fuchs-Hammoser, R., Maiga, M., Scherer, B., and Weber, P. C. ACTH stimulates plasma renin and angiotensin II in man. Clin Sci.(Lond) 61 Suppl 7:273s-275s (1981) | ||
| Seifert, C. and Oelkers, W. Aldosterone response to sodium deprivation and angiotensin II in patients with hypopituitarism. Acta Endocrinol (Copenh) 96(3):361-369 (1981) | ||
| 1980 | ||
| Bähr, V., Hansel, R., Tischer, I., and Weise, W. [Effect of pilocarpine on cell proliferation and the concentration of cyclic nucleotides in murine spleen cell preparations]. Arch.Pharm.(Weinheim) 313(7):653-655 (1980) | ||
| Belkien, L., Schoneshofer, M., and Oelkers, W. Development and characterization of antisera to 18- hydroxycorticosterone and 18-hydroxy-11-deoxycorticosterone and radioimmunoassay for serum 18-hydroxycorticosterone. Steroids 35:427-437 (1980) | ||
| Fuchs-Hammoser, R., Schweiger, M., and Oelkers, W. The effect of chronic low-dose infusion of ACTH (1-24) on renin, renin-substrate, aldosterone and other corticosteroids in sodium replete and deplete man. Acta Endocrinol (Copenh) 95(2):198-206 (1980) | ||
| Kleber, G., Hollt, V., Oelkers, W., and Quabbe, H. J. Elevated plasma and tissue concentrations of beta-endorphin and beta-lipotropin associated with an ectopic ACTH-producing lung tumor. Horm.Metab Res 12(8):385-389 (1980) | ||
| Oelkers, W. Idiopathic edema. Contrib.Nephrol. 23:47-54 (1980) | ||
| Schoneshofer, M. and Oelkers, W. Effect of prolonged infusions of angiotensin II on eight serum corticosteroids in man on different sodium diets. Horm Metab Res 12:614-620 (1980) | ||